<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurodev Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">J Neurodev Disord</journal-id>
<journal-title-group>
<journal-title>Journal of Neurodevelopmental Disorders</journal-title>
</journal-title-group>
<issn pub-type="ppub">1866-1947</issn>
<issn pub-type="epub">1866-1955</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31202261</article-id>
<article-id pub-id-type="pmc">6571119</article-id>
<article-id pub-id-type="publisher-id">9268</article-id>
<article-id pub-id-type="doi">10.1186/s11689-019-9268-y</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Impaired neurodevelopmental pathways in autism spectrum disorder: a review of signaling mechanisms and crosstalk</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kumar</surname>
<given-names>Santosh</given-names>
</name>
<address>
<email>samkumar@ucdavis.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reynolds</surname>
<given-names>Kurt</given-names>
</name>
<address>
<email>ksreynolds@ucdavis.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ji</surname>
<given-names>Yu</given-names>
</name>
<address>
<email>yvji@ucdavis.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gu</surname>
<given-names>Ran</given-names>
</name>
<address>
<email>rangu@ucdavis.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rai</surname>
<given-names>Sunil</given-names>
</name>
<address>
<email>skrrai@ucdavis.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8592-4680</contrib-id>
<name>
<surname>Zhou</surname>
<given-names>Chengji J.</given-names>
</name>
<address>
<email>cjzhou@ucdavis.edu</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9684</institution-id><institution-id institution-id-type="GRID">grid.27860.3b</institution-id><institution>Department of Biochemistry and Molecular Medicine, Institute for Pediatric Regenerative Medicine of Shriners Hospitals for Children, </institution><institution>University of California at Davis School of Medicine, </institution></institution-wrap>2425 Stockton Blvd, Sacramento, CA 95817 USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>15</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>11</volume>
<elocation-id>10</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>2</day>
<month>5</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2019</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">The development of an autistic brain is a highly complex process as evident from the involvement of various genetic and non-genetic factors in the etiology of the autism spectrum disorder (ASD). Despite being a multifactorial neurodevelopmental disorder, autistic patients display a few key characteristics, such as the impaired social interactions and elevated repetitive behaviors, suggesting the perturbation of specific neuronal circuits resulted from abnormal signaling pathways during brain development in ASD. A comprehensive review for autistic signaling mechanisms and interactions may provide a better understanding of ASD etiology and treatment.</p>
</sec>
<sec>
<title>Main body</title>
<p id="Par2">Recent studies on genetic models and ASD patients with several different mutated genes revealed the dysregulation of several key signaling pathways, such as WNT, BMP, SHH, and retinoic acid (RA) signaling. Although no direct evidence of dysfunctional FGF or TGF-β signaling in ASD has been reported so far, a few examples of indirect evidence can be found. This review article summarizes how various genetic and non-genetic factors which have been reported contributing to ASD interact with WNT, BMP/TGF-β, SHH, FGF, and RA signaling pathways. The autism-associated gene ubiquitin-protein ligase E3A (<italic>UBE3A</italic>) has been reported to influence WNT, BMP, and RA signaling pathways, suggesting crosstalk between various signaling pathways during autistic brain development. Finally, the article comments on what further studies could be performed to gain deeper insights into the understanding of perturbed signaling pathways in the etiology of ASD.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par3">The understanding of mechanisms behind various signaling pathways in the etiology of ASD may help to facilitate the identification of potential therapeutic targets and design of new treatment methods.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>WNT</kwd>
<kwd>BMP/TGF-β</kwd>
<kwd>SHH</kwd>
<kwd>FGF</kwd>
<kwd>Retinoic acid (RA)</kwd>
<kwd>Signaling crosstalk</kwd>
<kwd>Autism spectrum disorder</kwd>
<kwd>Neurodevelopmental disorders</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>R01NS102261</award-id>
<award-id>R01DE026737</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par49">Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental disorder characterized by impaired social interactions and elevated repetitive behaviors, in which various circuits in the sensory, prefrontal, hippocampal, cerebellar, striatal, and other midbrain regions are perturbed [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Compared to de novo non-coding variations, the de novo coding variants have a strong association with ASD as shown by the whole-genome sequence association (WGSA) studies in 519 ASD families [<xref ref-type="bibr" rid="CR3">3</xref>]. Kosmicki et al. further showed <italic>CHD8</italic>, <italic>ARID1B</italic>, <italic>DYRK1A</italic>, <italic>SYNGAP1</italic>, <italic>ADNP</italic>, <italic>ANK2</italic>, <italic>DSCAM</italic>, <italic>SCN2A</italic>, <italic>ASH1L</italic>, <italic>CHD2</italic>, <italic>KDM5B</italic>, and <italic>POGZ</italic> genes with ≥ 3 class 1 de novo protein-truncating variants (PTVs) in individuals with ASD [<xref ref-type="bibr" rid="CR4">4</xref>]. <italic>ANK2</italic>, <italic>CHD8</italic>, <italic>CUL3</italic>, <italic>DYRK1A</italic>, <italic>GRIN2B</italic>, <italic>KATNAL2</italic>, <italic>POGZ</italic>, <italic>SCN2A</italic>, and <italic>TBR1</italic> genes are identified as high-confidence ASD risk genes, of which <italic>CHD8</italic> is strongly associated with ASD because of the largest number of de novo loss-of-function (LOF) mutations observed in patients [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Various gene mutations reported in ASD patients are either core components of the WNT signaling pathway or their modulators [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR9">9</xref>]. More recently, a few reports support the idea of modulation of bone morphogenetic protein (BMP) signaling as a contributing factor in ASD model organisms and humans. For instance, Neuroligins (<italic>NLGN</italic>), fragile X mental retardation 1 (<italic>FMR1</italic>), ubiquitin-protein ligase E3A (<italic>UBE3A)</italic>, and <italic>DLX</italic>, which modulate BMP signaling, have been found to be associated with ASD [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]. Dysregulation of sonic hedgehog (SHH) [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], fibroblast growth factor (FGF) [<xref ref-type="bibr" rid="CR16">16</xref>], transforming growth factor β (TGF-β) [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>], and retinoic acid (RA) [<xref ref-type="bibr" rid="CR19">19</xref>] signaling pathways have also been implicated in the pathogenesis of ASD. Valproic acid (VPA), used in the treatment of epilepsy and bipolar disorder, may affect the WNT/β-catenin signaling pathway. However, its prenatal exposure in rats also causes susceptibility to autism [<xref ref-type="bibr" rid="CR20">20</xref>]. Due to the scarcity of information on the mechanisms underlying the etiologies of ASD, the success of therapeutic strategies is greatly limited.</p>
</sec>
<sec id="Sec2">
<title>Altered WNT signaling in ASD</title>
<p id="Par50">WNT signaling is fundamental for neurodevelopmental and post-neurodevelopmental processes, such as CNS regionalization, neural progenitor differentiation, neuronal migration, axon guidance, dendrite development, synaptogenesis, adult neurogenesis, and neural plasticity [<xref ref-type="bibr" rid="CR21">21</xref>–<xref ref-type="bibr" rid="CR30">30</xref>], and therefore, any perturbation in WNT signaling may trigger the advent of disorders related to the structures and functions of the CNS [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Studies in genetically modified animal models and human induced pluripotent stem cell (hiPSC) models, along with large-scale human genomic studies in several neurodevelopmental disorders over the last few decades, have revealed the importance of spatiotemporal regulation of WNT signaling throughout the lifespan of an animal [<xref ref-type="bibr" rid="CR9">9</xref>]. Moreover, dysregulation of WNT signaling has been reported in several psychiatric disorders, including ASD, bipolar disorder, and schizophrenia, as well as in case of intellectual disability [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR34">34</xref>]. Although several genetic and epigenetic factors have been linked with the etiologies of neurodevelopmental disorders, they often seem to affect a few common processes, such as chromatin remodeling, WNT signaling, and synaptic function [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Despite the heterogeneity in WNT signaling, it is broadly classified into “canonical” (β-catenin-dependent) and “non-canonical” (β-catenin-independent) pathways [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Both canonical and non-canonical WNT signaling pathways play crucial roles in neural development and related neurodevelopmental disorders.</p>
<sec id="Sec3">
<title>Genetic etiologies</title>
<p id="Par51">Several genetic loci/mutations linked to and/or reported in ASD patients are either core components of canonical WNT signaling, such as β-catenin (<italic>CTNNB1</italic>) [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR39">39</xref>] and adenomatous polyposis coli (<italic>APC</italic>) [<xref ref-type="bibr" rid="CR1">1</xref>], or non-canonical WNT signaling, such as <italic>PRICKLE2</italic> [<xref ref-type="bibr" rid="CR40">40</xref>], suggesting crucial roles of both canonical and non-canonical WNT signaling pathways in the etiologies of ASD (Table <xref ref-type="table" rid="Tab1">1</xref> and Fig. <xref ref-type="fig" rid="Fig1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Autism spectrum disorder (ASD) causal genes influencing WNT, BMP/TGF-β, SHH, FGF, and RA signaling pathways in vertebrates and invertebrates</p></caption><table frame="hsides" rules="groups"><thead><tr><th>ASD causal genes</th><th>Region/neurons/cells in which gene function is affected</th><th>Species</th><th>Affected signaling pathway</th><th>Phenotypes/downstream targets</th><th>Citations</th></tr></thead><tbody><tr><td><italic>5-HT</italic> GOF (gain-of-function)</td><td>Blood</td><td>Human</td><td>TGF-β</td><td>TGF-β pathway identified as a novel hyperserotonemia-related ASD genes</td><td>[<xref ref-type="bibr" rid="CR18">18</xref>]</td></tr><tr><td>
<italic>ALDH1A3</italic>
</td><td></td><td>Human</td><td>RA</td><td></td><td>[<xref ref-type="bibr" rid="CR135">135</xref>]</td></tr><tr><td><italic>ANK3</italic> LOF (loss-of-function)</td><td>P19 cells, proliferating neural progenitors of E16 mouse cortices, E15 brain slices</td><td>Mouse</td><td>WNT (canonical)</td><td>Increases proliferation of neural progenitor cells and nuclear β-catenin</td><td>[<xref ref-type="bibr" rid="CR85">85</xref>]</td></tr><tr><td><italic>APC</italic> LOF</td><td>Forebrain neurons, and hippocampal, cortical, and striatal regions</td><td>Mouse</td><td>WNT (canonical)</td><td>Learning and memory impairments and autistic-like behaviors (increased repetitive behaviors, reduced social interest)</td><td>[<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td>BTBR T<sup>+</sup> Itpr3<sup>tf</sup>/J (BTBR) mice</td><td>Spleen and brain tissues</td><td>Mouse</td><td>TGF-β</td><td>Decreased TGF-β levels</td><td>[<xref ref-type="bibr" rid="CR17">17</xref>]</td></tr><tr><td>
<italic>CD38</italic>
</td><td>Lymphoblastoid cell lines</td><td>Human and mouse</td><td>RA</td><td>Upregulation of CD38 by RA</td><td>[<xref ref-type="bibr" rid="CR140">140</xref>, <xref ref-type="bibr" rid="CR141">141</xref>]</td></tr><tr><td><italic>CHD8</italic><sup>−/−</sup> LOF</td><td>Whole</td><td>Mouse</td><td>WNT (canonical)</td><td>Embryonically lethal</td><td>[<xref ref-type="bibr" rid="CR87">87</xref>]</td></tr><tr><td><italic>CHD8</italic><sup>+/−</sup> LOF</td><td>Nucleus accumbens (NAc)</td><td>Mouse</td><td>WNT (canonical)</td><td>Macrocephaly, craniofacial abnormalities, and behavioral deficits; WNT signaling upregulates in the nucleus accumbens (NAc) region of the brain</td><td>[<xref ref-type="bibr" rid="CR89">89</xref>]</td></tr><tr><td><italic>CTNNB1</italic> LOF</td><td>Parvalbumin interneurons</td><td>Mouse</td><td>WNT (canonical)</td><td>Impaired object recognition and social interactions; elevated repetitive behaviors; enhanced spatial memory</td><td>[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td><italic>CTNNB1</italic> cKO LOF</td><td>Dorsal neural folds</td><td>Mouse</td><td>WNT (canonical)</td><td>Spina bifida aperta, caudal axis bending, and tail truncation</td><td>[<xref ref-type="bibr" rid="CR65">65</xref>]</td></tr><tr><td><italic>CTNNB1</italic> haploinsufficiency LOF</td><td>Whole</td><td>Human and mouse</td><td>WNT (canonical)</td><td>Neuronal loss, craniofacial anomalies, and hair follicle defects</td><td>[<xref ref-type="bibr" rid="CR64">64</xref>]</td></tr><tr><td><italic>DHCR7</italic> LOF</td><td>MEFs</td><td>Mouse</td><td>SHH</td><td>Impaired SMO and reduced SHH signaling</td><td>[<xref ref-type="bibr" rid="CR111">111</xref>]</td></tr><tr><td><italic>DIXDC1</italic> LOF</td><td>Mouse cortex</td><td>Human and mouse</td><td>WNT (canonical)</td><td>Impaired dendrite and spine growth, positive modulator of WNT signaling</td><td>[<xref ref-type="bibr" rid="CR79">79</xref>]</td></tr><tr><td><italic>Dlx5</italic> GOF</td><td>2B1 cell line</td><td>Mouse</td><td>BMP</td><td>Upregulation of BMP binding endothelial regulator (Bmper)</td><td>[<xref ref-type="bibr" rid="CR13">13</xref>]</td></tr><tr><td><italic>DNlg4</italic> LOF</td><td>NMJ</td><td>Drosophila</td><td>BMP</td><td>Reduced growth of neuromuscular junctions (NMJs) with fewer synaptic boutons</td><td>[<xref ref-type="bibr" rid="CR10">10</xref>]</td></tr><tr><td><italic>EN2</italic> GOF</td><td>Post-mortem samples</td><td>Human</td><td>SHH</td><td>Elevated SHH expression</td><td>[<xref ref-type="bibr" rid="CR117">117</xref>]</td></tr><tr><td><italic>FGF22</italic>/<italic>FGF7</italic> LOF</td><td>Hippocampal CA3 pyramidal neurons</td><td>Mouse</td><td>FGF</td><td>Impaired synapse formation</td><td>[<xref ref-type="bibr" rid="CR124">124</xref>]</td></tr><tr><td>FMRP depletion</td><td>COS-7 cells</td><td>Monkey</td><td>BMP</td><td>Increase in BMPR2 and activation of LIMK1, stimulates reorganization of actin to promote neurite outgrowth and synapse formation</td><td>[<xref ref-type="bibr" rid="CR11">11</xref>]</td></tr><tr><td>
<italic>FOXN1</italic>
</td><td></td><td>Human</td><td>RA</td><td></td><td>[<xref ref-type="bibr" rid="CR135">135</xref>]</td></tr><tr><td><italic>mGluR5</italic> LOF</td><td>Cortical neurons</td><td>Mouse</td><td>FGF</td><td>Increased NGF and FGF10 mRNA levels</td><td>[<xref ref-type="bibr" rid="CR125">125</xref>]</td></tr><tr><td>
<italic>PGE2</italic>
</td><td>Differentiating neuronal cells</td><td>Humans</td><td>WNT (canonical)</td><td>Upregulation of <italic>WNT3</italic> and <italic>TCF4</italic></td><td>[<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR94">94</xref>]</td></tr><tr><td><italic>PRICKLE2</italic> LOF</td><td>Hippocampal neurons</td><td>Mouse</td><td>WNT (non-canonical)</td><td>Altered social interaction, learning abnormalities, and behavioral inflexibility</td><td>[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td><italic>PTCHD1</italic> LOF</td><td>Dentate gyrus</td><td>Mouse</td><td>SHH (hypothetical)</td><td>SHH independent; disrupted synaptic transmission</td><td>[<xref ref-type="bibr" rid="CR109">109</xref>]</td></tr><tr><td>
<italic>RERE</italic>
</td><td></td><td>Human</td><td>RA</td><td></td><td>[<xref ref-type="bibr" rid="CR137">137</xref>]</td></tr><tr><td><italic>RORA</italic> LOF</td><td>Lymphoblastoid cell lines</td><td>Human</td><td>RA</td><td>Reduced protein levels of RORA and BCL-2 in autistic brain; aberrant methylation</td><td>[<xref ref-type="bibr" rid="CR133">133</xref>]</td></tr><tr><td><italic>TCF7L2</italic> LOF</td><td></td><td>Human and mouse</td><td>WNT (canonical)</td><td>Required for thalamocortical axonal projection formation</td><td>[<xref ref-type="bibr" rid="CR68">68</xref>–<xref ref-type="bibr" rid="CR71">71</xref>]</td></tr><tr><td><italic>UBE3A</italic> GOF</td><td>Prefrontal cortex</td><td>Mouse</td><td>RA</td><td>Negative regulation of ALDH1A2; impaired RA-mediated synaptic plasticity</td><td>[<xref ref-type="bibr" rid="CR139">139</xref>]</td></tr><tr><td><italic>ube3a</italic> LOF</td><td>NMJ</td><td>Drosophila</td><td>BMP</td><td>Compromised endocytosis in the NMJs and an upregulated BMP signaling in the nervous system</td><td>[<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td><italic>UBE3A</italic><sup>T485A</sup> LOF</td><td>HEK293T cells</td><td>Human</td><td>WNT (canonical)</td><td>Stabilizes nuclear β-catenin and stimulates canonical WNT signaling</td><td>[<xref ref-type="bibr" rid="CR78">78</xref>]</td></tr><tr><td><italic>WNT1</italic>, <italic>WNT2</italic>, <italic>WNT3</italic>, <italic>WNT9B</italic></td><td></td><td>Human</td><td>WNT (canonical)</td><td>Elevated <italic>WNT3</italic> expression in the prefrontal cortex of ASD patients</td><td>[<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr></tbody></table></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>Possible interactions between ASD causal genes and WNT signaling. Most molecules (red) encoded by the ASD-associated genes are either core components of WNT signaling pathways, such as WNTs, APC, β-catenin, TCF7L2, and PRICKLE2, or their modulators, such as DIXDC1, PGE2, UBE3A, and CHD8. ANK3 interacts with β-catenin at the plasma membrane. Note: plus sign indicates upregulation; minus sign indicates downregulation</p></caption><graphic id="MO1" xlink:href="11689_2019_9268_Fig1_HTML"></graphic></fig></p>
<sec id="Sec4">
<title>Core components of canonical WNT signaling</title>
<sec id="FPar1">
<title>WNTs</title>
<p id="Par52">Among 19 <italic>WNT</italic> ligands, mutations in <italic>WNT1</italic>, <italic>WNT2</italic>, <italic>WNT3</italic>, and <italic>WNT9B</italic> have been linked with ASD. A rare <italic>WNT1</italic> missense variant found in ASD patients has a higher capability than the wild-type <italic>WNT1</italic> to activate WNT/β-catenin signaling [<xref ref-type="bibr" rid="CR34">34</xref>]. Rare variants in <italic>WNT2</italic>, <italic>WNT3</italic>, and <italic>WNT9B</italic> have also been found in ASD patients [<xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR44">44</xref>]. Notably, <italic>WNT3</italic> expression is elevated in the prefrontal cortex of ASD patients [<xref ref-type="bibr" rid="CR45">45</xref>], suggesting overactivation of WNT signaling leads to ASD pathogenesis. In animal models, <italic>Wnt1</italic> is required for midbrain and cerebellar development [<xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref>]. <italic>Wnt2</italic> has been shown to be sufficient for cortical dendrite growth and dendritic spine formation, and its expression is regulated by a brain-derived neurotrophic factor (BDNF) [<xref ref-type="bibr" rid="CR49">49</xref>], while altered dendritic spines result in neurodevelopmental and neurodegenerative disorders [<xref ref-type="bibr" rid="CR49">49</xref>]. <italic>Wnt3</italic> is essential for gastrulation and regulates hippocampal neurogenesis [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. Loss-of-function of <italic>T-brain-1</italic> (<italic>Tbr1</italic>), a T-box transcription factor and one of the high-confidence ASD risk genes, in cortical layer 6 neurons (<italic>Tbr1</italic><sup>layer6</sup> mutant) during late mouse gestation has been reported to cause a decrease in inhibitory synaptic density and excitatory synapse numbers [<xref ref-type="bibr" rid="CR52">52</xref>]. It is important to note that the restoration of <italic>Wnt7b</italic> expression rescues the synaptic deficit in <italic>Tbr1</italic><sup>layer6</sup> mutant neurons [<xref ref-type="bibr" rid="CR52">52</xref>]. <italic>Wnt9b</italic> promotes lip/palate formation and fusion [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>], while its role in neurodevelopment remains unclear. In addition to the other WNT ligands, there are various types of WNT receptors, including FZD1 to FZD10, LRP5/6, RYK, and ROR1/2 [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR55">55</xref>], whose roles in ASD etiology remain elusive.</p>
</sec>
<sec id="FPar2">
<title>APC</title>
<p id="Par53">The tumor suppressor APC is a key component of the β-catenin-destruction complex [<xref ref-type="bibr" rid="CR56">56</xref>]. Human <italic>APC</italic> inactivating gene mutations have been linked to ASD [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>]. Compared with wild-type littermates, conditional knockout (cKO) <italic>Apc</italic> mice exhibit learning and memory impairment and autistic-like behaviors [<xref ref-type="bibr" rid="CR1">1</xref>]. β-catenin and canonical WNT target gene expressions (<italic>Dkk1</italic>, <italic>Sp5</italic>, <italic>Neurog1</italic>, <italic>Syn2</italic>) are increased in <italic>Apc-</italic>cKO forebrain neurons [<xref ref-type="bibr" rid="CR1">1</xref>]. Moreover, the lysates from the hippocampal, cortical, and striatal regions of <italic>Apc-</italic>cKO mice showed higher β-catenin levels compared to those of control mice [<xref ref-type="bibr" rid="CR1">1</xref>]. These results also indicate that overactivation of WNT/β-catenin signaling may be a cause of ASD.</p>
</sec>
<sec id="FPar3">
<title>CTNNB1 (β-catenin)</title>
<p id="Par54">β-Catenin is a key intracellular molecule in the canonical WNT signaling pathway and plays significant roles in development and disease [<xref ref-type="bibr" rid="CR59">59</xref>, <xref ref-type="bibr" rid="CR60">60</xref>]. De novo <italic>CTNNB1</italic> mutations have been reported in individuals with ASD, intellectual disability, microcephaly, motor delay, and speech impairment [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR61">61</xref>–<xref ref-type="bibr" rid="CR63">63</xref>]. <italic>CTNNB1</italic> haploinsufficiency has been found to cause neuronal loss, craniofacial anomalies, and hair follicle defects in both humans and mice [<xref ref-type="bibr" rid="CR64">64</xref>]. Conditional ablation of β-catenin in the dorsal neural folds of mouse embryos represses the expression of <italic>Pax3</italic> and <italic>Cdx2</italic> at the dorsal posterior neuropore and leads to a decreased expression of the WNT/β-catenin signaling target genes <italic>T</italic>, <italic>Tbx6</italic>, and <italic>Fgf8</italic> at the tail bud, resulting in spina bifida aperta, caudal axis bending, and tail truncation [<xref ref-type="bibr" rid="CR65">65</xref>]. Conditional ablation of β-catenin in parvalbumin interneurons in mice leads to impaired object recognition and social interactions, as well as elevated repetitive behaviors, which are core symptoms of ASD patients, and surprisingly, they showed enhanced spatial memory [<xref ref-type="bibr" rid="CR66">66</xref>]. These mice have reduced c-Fos activity in the cortex, which is unaffected in the dentate gyrus and the amygdala, suggesting a cell type-specific role of β-catenin in the regulation of cognitive and autistic-like behaviors [<xref ref-type="bibr" rid="CR66">66</xref>].</p>
</sec>
<sec id="FPar4">
<title>TCF7L2 (TCF4)</title>
<p id="Par55">TCF7L2 is one of the TCF/LEF1 transcription factors in the canonical WNT/β-catenin signaling pathway and is associated with type II diabetes in humans [<xref ref-type="bibr" rid="CR67">67</xref>]. De novo loss-of-function variants of <italic>TCF7L2</italic> have been found in ASD patients [<xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. In mice, Tcf7l2 is required for the formation of thalamocortical axonal projections, as is the key Wnt co-receptor Lrp6 [<xref ref-type="bibr" rid="CR70">70</xref>, <xref ref-type="bibr" rid="CR71">71</xref>], suggesting that abnormal thalamocortical axonal inputs may contribute to ASD. It remains unclear if other members of the TCF/Lef1 transcription factors are associated with ASD.</p>
</sec>
</sec>
<sec id="Sec5">
<title>Core components of non-canonical WNT signaling</title>
<sec id="FPar5">
<title>PRICKLE2</title>
<p id="Par56"><italic>PRICKLE2</italic> variants (p.E8Q and p.V153I) have been reported in ASD patients [<xref ref-type="bibr" rid="CR40">40</xref>]. <italic>PRICKLE2</italic>’s role in ASD is further supported by the finding of a 3p interstitial deletion including <italic>PRICKLE2</italic> in identical twins with ASD [<xref ref-type="bibr" rid="CR72">72</xref>]. <italic>Prickle2</italic>-deficient mice display ASD-like phenotypes, such as altered social interaction, learning abnormalities, and behavioral inflexibility [<xref ref-type="bibr" rid="CR40">40</xref>]. PRICKLE2 is known to interact with post-synaptic density protein-95 (PSD-95), and this relationship is enhanced by Vangl2, a key component in the non-canonical WNT/PCP (planar cell polarity) pathway [<xref ref-type="bibr" rid="CR73">73</xref>]. Reduced dendrite branching, synapse number, and PSD size have been observed in hippocampal neurons of <italic>Prickle2</italic>-deficient mice [<xref ref-type="bibr" rid="CR40">40</xref>]. An in vitro study shows that Prickle1 and Prickle2 promote neurite outgrowth via a Dvl-dependent mechanism [<xref ref-type="bibr" rid="CR74">74</xref>]. Future works need to address the involvement of other PCP genes and the signaling interaction between the PCP and WNT/β-catenin signaling pathways in ASD etiology.</p>
</sec>
</sec>
<sec id="Sec6">
<title>Modulators and effectors of WNT signaling in ASD etiology</title>
<p id="Par57">Several ASD-associated genes are direct or indirect modulators of WNT signaling, such as ankyrin-G (<italic>ANK3</italic>) [<xref ref-type="bibr" rid="CR75">75</xref>–<xref ref-type="bibr" rid="CR77">77</xref>], chromodomain helicase DNA-binding protein 8 (<italic>CHD8</italic>) [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], HECT domain E3 ubiquitin ligase (<italic>UBE3A</italic>) [<xref ref-type="bibr" rid="CR78">78</xref>], DIX domain-containing 1 (<italic>DIXDC1</italic>) [<xref ref-type="bibr" rid="CR79">79</xref>], and Prostaglandin E2 (<italic>PGE2</italic>) [<xref ref-type="bibr" rid="CR80">80</xref>] (Table <xref ref-type="table" rid="Tab1">1</xref> and Fig. <xref ref-type="fig" rid="Fig1">1</xref>). Intriguingly, a recent study suggests that the ASD-associated gene Neuroligin 3 (Nlgn3) is a direct downstream target of WNT/β-catenin signaling during synaptogenesis [<xref ref-type="bibr" rid="CR81">81</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).</p>
<sec id="FPar6">
<title>ANK3</title>
<p id="Par58">Whole-genome and whole-exome sequencing studies in ASD patients have identified mutations in <italic>ANK3</italic> gene [<xref ref-type="bibr" rid="CR75">75</xref>–<xref ref-type="bibr" rid="CR77">77</xref>]. Ankyrin-G, a scaffolding protein encoded by <italic>ANK3</italic> gene, localizes to the axon initial segment (AIS) and the nodes of Ranvier, where it has roles in the assembly and maintenance of the AIS and neuronal polarity [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>]. Ankyrin-G facilitates cell-cell contact by binding to E-cadherin at a conserved site distinct from that of β-catenin and localizes it to the cell adhesion site along with β-2-spectrin in early embryos and cultured epithelial cells [<xref ref-type="bibr" rid="CR84">84</xref>]. Ankyrin-G is enriched at the ventricular zone of the embryonic brain, where it regulates the proliferation of neural progenitor cells [<xref ref-type="bibr" rid="CR85">85</xref>]. Ankyrin-G LOF increases the proliferation of neural progenitor cells and nuclear β-catenin, probably by disruption of the β-catenin/cadherin interaction [<xref ref-type="bibr" rid="CR85">85</xref>].</p>
</sec>
<sec id="FPar7">
<title>CHD8</title>
<p id="Par59">CHD8, an ATP-dependent chromatin remodeler, interacts with β-catenin and negatively regulates the expression of β-catenin-targeted genes [<xref ref-type="bibr" rid="CR86">86</xref>]. CHD8 binding to p53 leads to the formation of a trimeric complex with histone H1 on chromatin, which suppresses p53-dependent transactivation and apoptosis during early embryogenesis [<xref ref-type="bibr" rid="CR87">87</xref>]. CHD8 is also required for the expression of E2 adenovirus promoter-binding factor target genes during the G1/S transition of the cell cycle [<xref ref-type="bibr" rid="CR88">88</xref>]. <italic>Chd8</italic> gene knockout (<italic>Chd8</italic><sup>−/−</sup>) in mice is embryonic lethal [<xref ref-type="bibr" rid="CR87">87</xref>], whereas its heterozygous LOF mutations (<italic>Chd8</italic><sup>+/−</sup>) result in mice with macrocephaly, craniofacial abnormalities, and behavioral deficits [<xref ref-type="bibr" rid="CR89">89</xref>]. Its knockdown in SK-N-SH human neural progenitor cells alters the expression of genes involved in neuronal development [<xref ref-type="bibr" rid="CR90">90</xref>]. WNT signaling is upregulated in the nucleus accumbens (NAc) region of the brain of <italic>Chd8</italic><sup>+/−</sup> mice, highlighting the critical role CHD8 plays in the regulation of WNT signaling in the NAc [<xref ref-type="bibr" rid="CR89">89</xref>].</p>
</sec>
<sec id="FPar8">
<title>UBE3A</title>
<p id="Par60">Dysfunction of <italic>UBE3A</italic> is linked to autism, Angelman syndrome, and cancer [<xref ref-type="bibr" rid="CR78">78</xref>]. <italic>UBE3A</italic><sup>T485A</sup>, a de novo autism-linked <italic>UBE3A</italic> mutant that disrupts phosphorylative control of UBE3A activity, ubiquitinates multiple proteasome subunits, reduces proteasome subunit abundance and activity, stabilizes nuclear β-catenin, and stimulates canonical WNT signaling more effectively than the wild-type UBE3A [<xref ref-type="bibr" rid="CR78">78</xref>].</p>
</sec>
<sec id="FPar9">
<title>DIXDC1</title>
<p id="Par61">Rare missense variants in <italic>DIXDC1</italic> were identified in ASD patients [<xref ref-type="bibr" rid="CR79">79</xref>]. These variants prevent phosphorylation of DIXDC1 isoform 1, causing impairment to dendrite and spine growth [<xref ref-type="bibr" rid="CR79">79</xref>]. DIXDC1 is a positive modulator for WNT signaling and regulates excitatory neuron dendrite development and synapse function in the mouse cortex [<xref ref-type="bibr" rid="CR79">79</xref>]. MARK1, which is also linked to ASD, phosphorylates DIXDC1 to regulate dendrite and spine development through modulation of the cytoskeletal network in an isoform-specific manner [<xref ref-type="bibr" rid="CR79">79</xref>]. Dixdc1-deficient mice exhibit behavioral disorders, including reduced social interaction, which can be alleviated through pharmacological inhibition of Gsk3 to upregulate WNT/β-catenin signaling [<xref ref-type="bibr" rid="CR91">91</xref>, <xref ref-type="bibr" rid="CR92">92</xref>]. These studies suggest a potential approach to ASD treatment through manipulation of WNT/β-catenin signaling activities.</p>
</sec>
<sec id="FPar10">
<title>PGE2</title>
<p id="Par62">PGE2, an endogenous lipid molecule, has been linked to ASD and alters the expression of downstream WNT-regulated genes previously associated with neurodevelopmental disorders [<xref ref-type="bibr" rid="CR80">80</xref>]. The link between prostaglandin and autism came from the report of Möbius sequence with autism and positive history of misoprostol use during pregnancy [<xref ref-type="bibr" rid="CR93">93</xref>]. The prostaglandin analog misoprostol is used as an abortifacient as well as for the prevention of gastric ulcers. Among seven children with ASD, four (57.1%) had prenatal exposure to misoprostol [<xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR94">94</xref>]. In undifferentiated stem cells, PGE2 downregulates <italic>PTGS2</italic> expression and upregulates <italic>MMP9</italic> and <italic>CCND1</italic> expression, whereas in differentiating neuronal cells, PGE2 causes upregulation of <italic>WNT3</italic>, <italic>TCF4</italic>, and <italic>CCND1</italic> [<xref ref-type="bibr" rid="CR80">80</xref>].</p>
</sec>
<sec id="FPar11">
<title>NLGN3</title>
<p id="Par63">Mutations in neuroligins <italic>NLGN3</italic> and <italic>NLGN4</italic> have been reported in autistic patients [<xref ref-type="bibr" rid="CR95">95</xref>]. These type I transmembrane proteins are neural cell adhesion molecules and are required for the formation and development of synapses [<xref ref-type="bibr" rid="CR10">10</xref>]. Chromatin immunoprecipitation and promoter luciferase assays demonstrate that WNT/β-catenin signaling directly regulates Nlgn3 expression [<xref ref-type="bibr" rid="CR81">81</xref>]. It will be important to address whether WNT/β-catenin signaling regulates other ASD-associated genes.</p>
</sec>
</sec>
</sec>
</sec>
<sec id="Sec7">
<title>Altered TGF-β/BMP signaling in ASD</title>
<p id="Par64">The TGF-β/activin and the bone morphogenetic protein (BMP)/growth and differentiation factor (GDF) are the two subgroups of TGF-β superfamily [<xref ref-type="bibr" rid="CR96">96</xref>]. BMPs constitute the largest subdivision of the TGF-β superfamily [<xref ref-type="bibr" rid="CR97">97</xref>] and are critical in the development of the nervous system [<xref ref-type="bibr" rid="CR98">98</xref>]. Their signaling has been shown to be dysregulated in ASD. BMPs regulate the expression of various genes by the canonical pathway (Smad-dependent) and non-canonical pathways (such as MAPK cascade) [<xref ref-type="bibr" rid="CR99">99</xref>]. In the canonical pathway, the binding of BMPs to type I or type II serine/threonine kinase receptors forms a heterotetrameric complex. This leads to the transphosphorylation of the type I receptor by the type II receptor. The type I receptor then phosphorylates the R-Smads (Smad1/5/8). The phosphorylated Smad1/5/8 along with the co-Smad (Smad4) translocate to the nucleus and regulate gene expression. There are various factors such as plasma membrane co-receptors and extracellular and intracellular factors known to modulate BMP signaling [<xref ref-type="bibr" rid="CR99">99</xref>]. BTBR T<sup>+</sup>Itpr3<sup>tf</sup>/J (BTBR) mice are widely used in the study of ASD [<xref ref-type="bibr" rid="CR17">17</xref>]. It has been reported that TGF-β levels are reduced in BTBR mice in comparison with B6 mice [<xref ref-type="bibr" rid="CR17">17</xref>] (Table <xref ref-type="table" rid="Tab1">1</xref>). Significant changes in the expression of TGF-β have been found in the spleen and brain tissues of BTBR mice compared to those in adenosine A2A receptor (A2AR) agonist CGS 21680 (CGS)-treated mice [<xref ref-type="bibr" rid="CR17">17</xref>]. ASD has been linked with higher levels of serotonin (5-hydroxytryptamine or 5-HT) in the blood [<xref ref-type="bibr" rid="CR18">18</xref>] (Table <xref ref-type="table" rid="Tab1">1</xref>). In a network-based gene set enrichment analysis (NGSEA), components of the TGF-β pathway have been identified as novel hyperserotonemia-related ASD genes, based on LOF and missense de novo variants (DNVs) [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
<sec id="FPar12">
<title>NLGN4</title>
<p id="Par65">Drosophila neuroligin 4 (<italic>DNlg4</italic>) LOF results in reduced growth of neuromuscular junctions (NMJs), with fewer synaptic boutons due to the reduction in the bone morphogenetic protein (BMP) type I receptor thickvein (<italic>Tkv</italic>) [<xref ref-type="bibr" rid="CR10">10</xref>], suggesting important roles of BMP signaling in normal and autistic brains.</p>
</sec>
<sec id="FPar13">
<title>FMR1</title>
<p id="Par66">Fragile X syndrome (FXS) is the most common heritable form of intellectual disability and ASD, which is caused due to the silencing of <italic>FMR1</italic> [<xref ref-type="bibr" rid="CR11">11</xref>]. FMR1 protein (FMRP) depletion results in an increase in the bone morphogenetic protein type II receptor (<italic>BMPR2</italic>) and activation of a non-canonical BMP signaling component LIM domain kinase 1 (<italic>LIMK1</italic>), which stimulates reorganization of actin to promote neurite outgrowth and synapse formation [<xref ref-type="bibr" rid="CR11">11</xref>]. Increased <italic>BMPR2</italic> and <italic>LIMK1</italic> activity has been reported in the prefrontal cortex of FXS patients compared with that of healthy subjects [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
</sec>
<sec id="FPar14">
<title>UBE3A</title>
<p id="Par67">The inhibition of BMP signaling by Ube3a has been reported to play a role in the regulation of synapse growth and endocytosis [<xref ref-type="bibr" rid="CR12">12</xref>]. A direct substrate of ube3a, the BMP receptor Tkv, is degraded through the ubiquitin-proteasome pathway [<xref ref-type="bibr" rid="CR12">12</xref>]. Drosophila ube3a has been known to regulate the NMJ development in the presynaptic neurons through the BMP signaling pathway [<xref ref-type="bibr" rid="CR12">12</xref>]. Drosophila ube3a mutants have been shown viable and fertile. However, they display compromised endocytosis in the NMJs and upregulated BMP signaling in the nervous system due to an increase in <italic>Tkv</italic> [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
</sec>
<sec id="FPar15">
<title>DLX</title>
<p id="Par68">The <italic>DLX</italic> genes encoding homeodomain transcription factors have been associated with ASD [<xref ref-type="bibr" rid="CR100">100</xref>–<xref ref-type="bibr" rid="CR102">102</xref>]. These genes control craniofacial patterning and differentiation and survival of forebrain inhibitory neurons [<xref ref-type="bibr" rid="CR100">100</xref>]. The BMP-binding endothelial regulator (<italic>Bmper</italic>) has been found upregulated in a cell line overexpressing <italic>Dlx5</italic> [<xref ref-type="bibr" rid="CR13">13</xref>], suggesting dysregulated <italic>DLX</italic> function in ASD patients may lead to altered BMP signaling.</p>
</sec>
</sec>
<sec id="Sec12">
<title>Altered SHH signaling in ASD</title>
<p id="Par69">SHH plays a crucial role in the organization of the vertebrate brain [<xref ref-type="bibr" rid="CR103">103</xref>]. SHH has a wide range of roles in developing as well as the adult brain and drives proliferation, specification, and axonal targeting within the forebrain, hindbrain, and spinal cord [<xref ref-type="bibr" rid="CR104">104</xref>]. Although the role of neural primary cilia in embryonic CNS patterning is well studied, their role in adult CNS plasticity has recently emerged [<xref ref-type="bibr" rid="CR105">105</xref>]. SHH signaling at the primary cilium has been described [<xref ref-type="bibr" rid="CR106">106</xref>] and is summarized in Fig. <xref ref-type="fig" rid="Fig2">2</xref>. In the absence of SHH activity, PTCH represses SMO. This leads to the phosphorylation of GLI proteins, and their subsequent proteolytic truncation into repressor forms that inhibit transcriptional activity. However, the binding of SHH to PTCH causes its internalization followed by degradation which in turn leads to SMO accumulation and phosphorylation. In this case, GLI is transported to the cytosol and enters the nucleus in its full form, which further activates target transcription. Pathological roles of SHH, Indian hedgehog (IHH), and BDNF have been suggested in children with ASD [<xref ref-type="bibr" rid="CR14">14</xref>]. SHH signaling influences neurogenesis and neural patterning during the development of the central nervous system. Dysregulation of SHH signaling in the brain leads to neurological disorders like ASD [<xref ref-type="bibr" rid="CR15">15</xref>]. SHH has also been associated with oxidative stress in autism [<xref ref-type="bibr" rid="CR107">107</xref>]. Significantly higher levels of oxygen free radicals (OFR) and serum SHH protein have been demonstrated in autistic children, suggesting a pathological role of oxidative stress and SHH in ASD [<xref ref-type="bibr" rid="CR108">108</xref>]. Figure <xref ref-type="fig" rid="Fig2">2</xref> summarizes the interaction between ASD causal genes and SHH signaling.<fig id="Fig2"><label>Fig. 2</label><caption><p>Possible interactions between ASD causal genes and SHH signaling. The genes encoded for PTCHD1, EN2, and DHCR7 are potential ASD genes. Note: minus sign indicates downregulation; question mark indicates undefined role of PTCHD1 in SHH signaling</p></caption><graphic id="MO2" xlink:href="11689_2019_9268_Fig2_HTML"></graphic></fig></p>
<sec id="FPar16">
<title>PTCHD1</title>
<p id="Par70">Mutations in the gene patched domain-containing 1 (<italic>PTCHD1</italic>) have been reported in ASD and ID patients [<xref ref-type="bibr" rid="CR109">109</xref>]. <italic>Ptchd1</italic> KO male mice exhibit cognitive alterations [<xref ref-type="bibr" rid="CR109">109</xref>]. LOF experiments do not support a role for PTCHD1 protein in SHH-dependent signaling but reveal a disruption of synaptic transmission in the mouse dentate gyrus [<xref ref-type="bibr" rid="CR109">109</xref>]. PTCHD1 has been shown to bind with the post-synaptic proteins PSD95 and SAP102 [<xref ref-type="bibr" rid="CR110">110</xref>]. Ptchd1 deficiency in male mice (<italic>Ptchd1</italic><sup><italic>−/y</italic></sup>) induces global changes in synaptic gene expression, affects the expression of the immediate-early expression genes <italic>Egr1</italic> and <italic>Npas4</italic>, and impairs excitatory synaptic structure and neuronal excitatory activity in the hippocampus, leading to cognitive dysfunction, motor disabilities, and hyperactivity [<xref ref-type="bibr" rid="CR110">110</xref>].</p>
</sec>
<sec id="FPar17">
<title>DHCR7</title>
<p id="Par71">The impaired function of the cholesterol biosynthetic enzyme 7-dehydrocholesterol reductase (<italic>DHCR7</italic>) has been associated with the ASD [<xref ref-type="bibr" rid="CR111">111</xref>]. The activation of the transmembrane protein Smoothened (SMO), through which SHH signaling is transduced, and its localization to the primary cilium is affected by conditions of reduced cholesterol biosynthesis [<xref ref-type="bibr" rid="CR111">111</xref>].</p>
</sec>
<sec id="FPar18">
<title>EN2</title>
<p id="Par72">The transcription factor engrailed2 (EN2) has been associated with ASD [<xref ref-type="bibr" rid="CR112">112</xref>–<xref ref-type="bibr" rid="CR116">116</xref>]. The increased levels of <italic>EN2</italic> in affected individuals with <italic>EN2</italic> ASD-associated haplotype (rs1861972-rs1861973 A-C) further support the susceptibility of <italic>EN2</italic> gene for ASD [<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR117">117</xref>, <xref ref-type="bibr" rid="CR118">118</xref>]. The increased <italic>EN2</italic> levels result in the elevated levels of the <italic>SHH</italic> expression as reported in post-mortem samples [<xref ref-type="bibr" rid="CR117">117</xref>]. <italic>SHH</italic> is one of the genes flanking <italic>EN2</italic> which is coexpressed during brain development [<xref ref-type="bibr" rid="CR119">119</xref>, <xref ref-type="bibr" rid="CR120">120</xref>].</p>
</sec>
</sec>
<sec id="Sec16">
<title>Altered FGF signaling in ASD</title>
<p id="Par73">FGF signaling plays a crucial role in brain patterning, and its malfunction can result in various neurological disorders [<xref ref-type="bibr" rid="CR121">121</xref>]. There are 18 secreted FGFs and 4 tyrosine kinase FGF receptors (FGFRs) reported in the mammalian FGF family whose interaction is regulated by cofactors and extracellular binding proteins [<xref ref-type="bibr" rid="CR122">122</xref>]. Activation of FGFRs leads to the phosphorylation of tyrosine residues which further results in the interaction between cytosolic adaptor proteins and the RAS-MAPK, PI3K-AKT, PLCγ, and STAT intracellular signaling pathways [<xref ref-type="bibr" rid="CR122">122</xref>]. Dysregulation of FGF signaling has been suggested to play a role in the pathogenesis of ASD [<xref ref-type="bibr" rid="CR16">16</xref>]. For instance, cortical abnormalities observed in autistic brains have been associated with defective FGF signaling [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR123">123</xref>]. Perturbations in the number of excitatory and inhibitory synapses have been implicated in ASD [<xref ref-type="bibr" rid="CR124">124</xref>]. Mutant mice lacking FGF22 or FGF7, which displayed impaired synapse formation in the hippocampal CA3 pyramidal neurons, have been reported [<xref ref-type="bibr" rid="CR124">124</xref>], supporting the pathological role of dysregulated FGF signaling in ASD (Table <xref ref-type="table" rid="Tab1">1</xref>). The metabotropic glutamate receptor 5 (<italic>mGluR5</italic>) LOF results in aberrant dendritogenesis, one of the characteristics observed in autistic brains, in the cortical neurons by increasing nerve growth factor (NGF) and FGF10 mRNA levels [<xref ref-type="bibr" rid="CR125">125</xref>] (Table <xref ref-type="table" rid="Tab1">1</xref>).</p>
</sec>
<sec id="Sec17">
<title>Altered retinoic acid signaling in ASD</title>
<p id="Par74">Retinoic acid (RA), the functional metabolite of vitamin A, is an essential morphogen in vertebrate development [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>]. RA mediates both genomic transcriptional effects by binding to nuclear receptors called retinoic acid receptors (RARs) and retinoid X receptors (RXRs) as well as non-genomic effects such as retinoylation (RA acylation), a post-translational modification of proteins [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>]. A range of co-activators and co-repressors have been reported in modulating RA signaling activity [<xref ref-type="bibr" rid="CR129">129</xref>]. In the developing CNS, RA is required for neural patterning, differentiation, proliferation, and the establishment of neurotransmitter systems [<xref ref-type="bibr" rid="CR130">130</xref>]. RA from the meninges regulates cortical neuron generation [<xref ref-type="bibr" rid="CR131">131</xref>]. Vitamin A deficiency may induce ASD-like behaviors in rats [<xref ref-type="bibr" rid="CR132">132</xref>]. It has been proposed that an abnormality in the interplay between retinoic acid and sex hormones may cause ASD [<xref ref-type="bibr" rid="CR19">19</xref>]. Aberrant methylation and decreased protein expression of retinoic acid-related orphan receptor alpha (RORA) have been found in the autistic brain [<xref ref-type="bibr" rid="CR133">133</xref>], while <italic>RORA</italic> variants have been associated with ASD [<xref ref-type="bibr" rid="CR134">134</xref>]. Whole-exome sequencing in a South American cohort links RA signaling genes, including an RA-synthesizing gene aldehyde dehydrogenase 1 family member A3 (<italic>ALDH1A3</italic>) and the RORA-regulated <italic>FOXN1</italic> to ASD [<xref ref-type="bibr" rid="CR135">135</xref>]. Low level of <italic>ALDH1A1</italic> has been found in a subset of autistic patients [<xref ref-type="bibr" rid="CR136">136</xref>]. De novo mutations in arginine-glutamic acid dipeptide repeats (<italic>RERE</italic>) that encode a nuclear receptor coregulator for RA signaling may cause ASD and other defects associated with proximal 1p36 deletions [<xref ref-type="bibr" rid="CR137">137</xref>]. Genome-wide chromatin immunoprecipitation analysis revealed that RORA transcriptionally regulates several ASD-relevant genes, including <italic>NLGN1</italic> [<xref ref-type="bibr" rid="CR138">138</xref>]. Intriguingly, overexpression of UBE3A represses <italic>ALDH1A2</italic> and impairs RA-mediated synaptic plasticity in ASD, which can be alleviated by RA supplements [<xref ref-type="bibr" rid="CR139">139</xref>]. All-<italic>trans</italic>-RA can upregulate the reduced CD38 expression in lymphoblastoid cell lines from ASD, while CD38-deficient mice exhibit ASD-like behavior [<xref ref-type="bibr" rid="CR140">140</xref>, <xref ref-type="bibr" rid="CR141">141</xref>]. Beta-carotene, a precursor of vitamin A, has been shown as a potential treatment of autistic-like behavior in BTBR mice [<xref ref-type="bibr" rid="CR142">142</xref>]. A synthetic RORA/G agonist has been tested to alleviate autistic disorders in a mouse model [<xref ref-type="bibr" rid="CR143">143</xref>]. These studies suggest therapeutic approaches for treating ASD by targeting RA and related signaling pathways. The possible interactions among ASD causal genes and RA signaling have been described in Fig. <xref ref-type="fig" rid="Fig3">3</xref>.<fig id="Fig3"><label>Fig. 3</label><caption><p>Possible interactions between ASD causal genes and RA signaling. UBE3A affects ALDH1A expression and thereby affects retinoic acid signaling pathway. RORA is associated with ASD which influences NLGN1. The RA signaling coregulator RERE is also associated with ASD</p></caption><graphic id="MO3" xlink:href="11689_2019_9268_Fig3_HTML"></graphic></fig></p>
</sec>
<sec id="Sec18">
<title>Non-genetic etiologies of ASD and altered signaling pathways</title>
<p id="Par76">Various exogenous factors, such as prenatal exposure to viral infection or VPA, lead to several neurodevelopmental disorders with perturbed WNT signaling (Fig. <xref ref-type="fig" rid="Fig1">1</xref>). The transcription factor GATA-3 is critical for the brain development [<xref ref-type="bibr" rid="CR144">144</xref>] and is involved in the WNT [<xref ref-type="bibr" rid="CR145">145</xref>] and TGF-β/BMP [<xref ref-type="bibr" rid="CR146">146</xref>, <xref ref-type="bibr" rid="CR147">147</xref>] signaling pathways. An increase in binding to GATA sites in DNA has been reported while exposure to thalidomide, valproate, and alcohol is known to cause ASD [<xref ref-type="bibr" rid="CR148">148</xref>].</p>
<sec id="FPar19">
<title>Viral infection</title>
<p id="Par77">The infection with rubella in early pregnancy has been linked to autism in clinical and epidemiological studies [<xref ref-type="bibr" rid="CR149">149</xref>]. Prenatal viral-like immune activation has recently been reported to induce stable hyper- and hypomethylated CpGs at WNT signaling genomic regions (<italic>WNT3</italic>, <italic>WNT7B</italic>, <italic>WNT8A</italic>) which further disrupt the transcription of downstream target genes [<xref ref-type="bibr" rid="CR150">150</xref>], suggesting a potential role of epigenetic modulation of WNT signaling in ASD etiologies.</p>
</sec>
<sec id="FPar20">
<title>VPA</title>
<p id="Par78">The use of the anticonvulsant valproic acid (VPA) during early pregnancy has been reported to cause autism in 11% children and autistic traits in an even larger number of children [<xref ref-type="bibr" rid="CR151">151</xref>]. VPA is used in the treatment of epilepsy and bipolar disorder. However, rat prenatal exposure to VPA results in animals that are susceptible to autism-like phenotypes [<xref ref-type="bibr" rid="CR20">20</xref>]. Prenatally VPA-treated rats exhibit an imbalance in oxidative homeostasis that facilitates susceptibility to autism [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR152">152</xref>]. VPA treatment in rats resulted in lowered social interaction, longer moving time in the central area, and reduced standing times. Sulindac is a small molecule inhibitor of the WNT/β-catenin signaling pathway [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR152">152</xref>]. Sulindac treatment can correct the VPA-induced autistic-like behaviors, p-Gsk3β downregulation, and β-catenin upregulation in the prefrontal lobe, hippocampus, and cerebellum [<xref ref-type="bibr" rid="CR152">152</xref>].</p>
</sec>
</sec>
<sec id="Sec21">
<title>Conclusions</title>
<p id="Par79">ASD causal genes may act upstream or downstream of WNT, BMP/TGFβ, SHH, FGF, and RA signaling pathways in vertebrates and invertebrates (Table <xref ref-type="table" rid="Tab1">1</xref> and Figs. <xref ref-type="fig" rid="Fig1">1</xref>, <xref ref-type="fig" rid="Fig2">2</xref>, <xref ref-type="fig" rid="Fig3">3</xref>, and <xref ref-type="fig" rid="Fig4">4</xref>). Alteration in these signaling pathways during brain development seems to cause ASD and other neurodevelopmental disorders. Previous studies support possible roles for these signaling pathways in the design of therapeutic targets for autism. However, systematic developmental studies are required to identify the temporal window in which impairment of these signals has the most significant impact on brain structure and function and resulting behavioral impairment. Such studies may also help in elucidating the upstream and downstream signaling pathways in the etiology of neurodevelopmental disorders as well as the mechanisms behind a particular impaired behavior. Although crosstalk among signaling pathways has been reported in several developmental processes and related diseases, similar studies in autistic models are lacking. Crosstalk between WNT and Hedgehog/Gli signaling in colon cancer has been studied and suggested as a potential target for its treatment [<xref ref-type="bibr" rid="CR153">153</xref>]. β-Catenin and Gli1 are negatively regulated by GSK3β and CK1α [<xref ref-type="bibr" rid="CR154">154</xref>–<xref ref-type="bibr" rid="CR156">156</xref>] and have antagonistic roles in regulating TCF and downstream target genes in metastatic colon cancer [<xref ref-type="bibr" rid="CR157">157</xref>]. The suppressor of the fused kinase (Sufu), a negative regulator of Gli1, has been reported to regulate the distribution of β-catenin in the nucleus and cytoplasm [<xref ref-type="bibr" rid="CR158">158</xref>–<xref ref-type="bibr" rid="CR160">160</xref>]. In colon cancer, loss of either PTEN or p53 leads to the activation of both β-catenin and Gli1 [<xref ref-type="bibr" rid="CR157">157</xref>, <xref ref-type="bibr" rid="CR161">161</xref>]. The inhibition of SMO, an upstream active factor of Gli1, has been shown to reduce active β-catenin levels and induce its nuclear exclusion [<xref ref-type="bibr" rid="CR162">162</xref>]. Gli1 negatively regulates Gli3R and vice versa [<xref ref-type="bibr" rid="CR157">157</xref>]. Further, Gli3R has been shown to inhibit the activity of β-catenin [<xref ref-type="bibr" rid="CR163">163</xref>]. The transcription of <italic>Wnt2b</italic>, <italic>Wnt4</italic>, and <italic>Wnt7b</italic> is shown to be induced by Gli1 [<xref ref-type="bibr" rid="CR164">164</xref>]. The crosstalk between TGF-β and SHH pathways has also been reported in cancer [<xref ref-type="bibr" rid="CR165">165</xref>], as well as in cyclosporine-enhanced cell proliferation in human gingival fibroblasts [<xref ref-type="bibr" rid="CR166">166</xref>]. Neuropilin-1 (NRP1), a TGF-β co-receptor expressed on the membrane of cancer cells, is known to enhance the canonical SMAD2/3 signaling in response to TGF-β [<xref ref-type="bibr" rid="CR167">167</xref>]. Further, HH signaling increases NRP1 transcription and NRP1 is also reported to increase the activation of HH target genes by mediating HH transduction between activated SMO and SUFU [<xref ref-type="bibr" rid="CR168">168</xref>, <xref ref-type="bibr" rid="CR169">169</xref>]. While TGF-β is important for SMO-mediated cancer development [<xref ref-type="bibr" rid="CR170">170</xref>], its role in the induction of GLI2 and GLI1 expression by inhibition of PKA activity has also been reported [<xref ref-type="bibr" rid="CR171">171</xref>]. A hierarchical pattern of crosstalk has been suggested in which TGF-β upregulates Shh and leads to cyclosporine-enhanced Shh expression and cell proliferation in gingival fibroblasts [<xref ref-type="bibr" rid="CR166">166</xref>]. Crosstalk between FGF and WNT pathways has been observed in zebrafish tailbud [<xref ref-type="bibr" rid="CR172">172</xref>] and mouse craniofacial development [<xref ref-type="bibr" rid="CR173">173</xref>]. Reciprocal positive regulation between FGF and WNT signaling has been observed [<xref ref-type="bibr" rid="CR172">172</xref>]. WNT/β-catenin signaling in the anterior neural ridge and facial ectoderm has been shown to positively target Fgf8, and β-catenin GOF leads to ectopic expression of Fgf8 in the facial ectoderm [<xref ref-type="bibr" rid="CR173">173</xref>]. Wnt has been reported to increase FGF signaling within the Mapk branch by elevating Erk phosphorylation levels [<xref ref-type="bibr" rid="CR172">172</xref>]. Further, Fgf has been shown to inhibit the Wnt antagonists, dkk1 and notum1a, resulting in the elevation of WNT signaling [<xref ref-type="bibr" rid="CR172">172</xref>]. A LOF mutation in <italic>UBE3A</italic>, an ASD-associated gene, influences both the WNT and BMP signaling pathways, suggesting possible crosstalk between them [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. Xu et al. further demonstrated that excessive <italic>UBE3A</italic> impairs RA-mediated neuronal synaptic plasticity in ASD probably by negative regulation of ALDH1A2, the rate-limiting enzyme of retinoic acid (RA) synthesis. [<xref ref-type="bibr" rid="CR139">139</xref>]. Medina et al. [<xref ref-type="bibr" rid="CR81">81</xref>] suggested that while <italic>Nlgn3</italic> is a direct target of WNT/β-catenin signaling, the ASD-associated gene may also regulate BMP signaling. These results suggest that signaling crosstalk among morphogenetic pathways is mediated by autistic causal genes, thereby demonstrating value in further in-depth studies on interactions between signaling molecules in normal physiological and diseased conditions. Evidence has suggested a tissue-specific mechanism behind WNT and BMP signaling crosstalk [<xref ref-type="bibr" rid="CR174">174</xref>]. Moreover, WNT signaling may repress RA signaling during orofacial development [<xref ref-type="bibr" rid="CR175">175</xref>], while WNT signaling positively regulates RA signaling in the dorsal optic cup during eye development [<xref ref-type="bibr" rid="CR176">176</xref>], suggesting context-dependent mechanisms of signaling interactions. Therefore, the interaction between various signaling pathways should be studied in neuronal as well as glial cells for ASD, which may help in designing treatment and targeting perturbed signaling in a cell-specific manner. Among the nine high-confidence ASD risk genes, only a few have been studied so far in the context of impaired signaling pathways. The investigation of roles for other ASD genes in neurodevelopment and in the regulation of various signaling pathways may increase the understanding of mechanisms behind the etiology of ASD. Overall, this article proposes to study how different ASD causal genes interact with each signaling pathway in the development of the brain and whether there is any crosstalk between them.<fig id="Fig4"><label>Fig. 4</label><caption><p>ASD causal genes affecting BMP signaling and potential crosstalk with other signaling pathways. ASD causal genes-encoded proteins, such as NLGN3/4, FMR1, DLX, and UBE3A, interact with BMP signaling pathway which may further affect WNT signaling. It should be noted that overexpression of UBE3A affects WNT and RA signaling pathways. However, its loss-of-function affects BMP signaling. Note: plus sign indicates upregulation; minus sign indicates downregulation</p></caption><graphic id="MO4" xlink:href="11689_2019_9268_Fig4_HTML"></graphic></fig></p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>AIS</term>
<def>
<p id="Par4">Axon initial segment</p>
</def>
</def-item>
<def-item>
<term>ALDH1A3</term>
<def>
<p id="Par5">Aldehyde dehydrogenase 1 family member A3</p>
</def>
</def-item>
<def-item>
<term>ANK3</term>
<def>
<p id="Par6">Ankyrin-G</p>
</def>
</def-item>
<def-item>
<term>APC</term>
<def>
<p id="Par7">Adenomatous polyposis coli</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p id="Par8">Autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>BDNF</term>
<def>
<p id="Par9">Brain-derived neurotrophic factor</p>
</def>
</def-item>
<def-item>
<term>BMP</term>
<def>
<p id="Par10">Bone morphogenetic protein</p>
</def>
</def-item>
<def-item>
<term>Bmper</term>
<def>
<p id="Par11">BMP binding endothelial regulator</p>
</def>
</def-item>
<def-item>
<term>BMPR2</term>
<def>
<p id="Par12">Bone morphogenetic protein type II receptor</p>
</def>
</def-item>
<def-item>
<term>CHD8</term>
<def>
<p id="Par13">Chromodomain helicase DNA-binding protein 8</p>
</def>
</def-item>
<def-item>
<term>cKO</term>
<def>
<p id="Par14">Conditional knockout</p>
</def>
</def-item>
<def-item>
<term>CTNNB1</term>
<def>
<p id="Par15">β-Catenin</p>
</def>
</def-item>
<def-item>
<term>DHCR7</term>
<def>
<p id="Par16">7-Dehydrocholesterol reductase</p>
</def>
</def-item>
<def-item>
<term>DIXDC1</term>
<def>
<p id="Par17">DIX domain containing 1</p>
</def>
</def-item>
<def-item>
<term>DNlg4</term>
<def>
<p id="Par18">Drosophila neuroligin 4</p>
</def>
</def-item>
<def-item>
<term>DNVs</term>
<def>
<p id="Par19">De novo variants</p>
</def>
</def-item>
<def-item>
<term>EN2</term>
<def>
<p id="Par20">Engrailed2</p>
</def>
</def-item>
<def-item>
<term>FGF</term>
<def>
<p id="Par21">Fibroblast growth factor</p>
</def>
</def-item>
<def-item>
<term>FMR1</term>
<def>
<p id="Par22">Fragile X mental retardation 1</p>
</def>
</def-item>
<def-item>
<term>FMRP</term>
<def>
<p id="Par23">FMR1 protein</p>
</def>
</def-item>
<def-item>
<term>FXS</term>
<def>
<p id="Par24">Fragile X syndrome</p>
</def>
</def-item>
<def-item>
<term>GOF</term>
<def>
<p id="Par285">Gain-of-function</p>
</def>
</def-item>
<def-item>
<term>hiPSC</term>
<def>
<p id="Par25">Human induced pluripotent stem cell</p>
</def>
</def-item>
<def-item>
<term>IHH</term>
<def>
<p id="Par26">Indian hedgehog</p>
</def>
</def-item>
<def-item>
<term>LIMK1</term>
<def>
<p id="Par27">LIM domain kinase 1</p>
</def>
</def-item>
<def-item>
<term>LOF</term>
<def>
<p id="Par28">Loss-of-function</p>
</def>
</def-item>
<def-item>
<term>mGluR5</term>
<def>
<p id="Par29">Metabotropic glutamate receptor 5</p>
</def>
</def-item>
<def-item>
<term>NAc</term>
<def>
<p id="Par30">Nucleus accumbens</p>
</def>
</def-item>
<def-item>
<term>NGF</term>
<def>
<p id="Par31">Nerve growth factor</p>
</def>
</def-item>
<def-item>
<term>NGSEA</term>
<def>
<p id="Par32">Network-based gene set enrichment analysis</p>
</def>
</def-item>
<def-item>
<term>NLGN</term>
<def>
<p id="Par33">Neuroligins</p>
</def>
</def-item>
<def-item>
<term>Nlgn3</term>
<def>
<p id="Par34">Neuroligin 3</p>
</def>
</def-item>
<def-item>
<term>NMJs</term>
<def>
<p id="Par35">Neuromuscular junctions</p>
</def>
</def-item>
<def-item>
<term>OFR</term>
<def>
<p id="Par36">Oxygen free radicals</p>
</def>
</def-item>
<def-item>
<term>PCP</term>
<def>
<p id="Par37">Planar cell polarity</p>
</def>
</def-item>
<def-item>
<term>PGE2</term>
<def>
<p id="Par38">Prostaglandin E2</p>
</def>
</def-item>
<def-item>
<term>PTCHD1</term>
<def>
<p id="Par39">Patched domain-containing 1</p>
</def>
</def-item>
<def-item>
<term>RA</term>
<def>
<p id="Par40">Retinoic acid</p>
</def>
</def-item>
<def-item>
<term>RERE</term>
<def>
<p id="Par41">Arginine-glutamic acid dipeptide repeats</p>
</def>
</def-item>
<def-item>
<term>RORA</term>
<def>
<p id="Par42">Retinoic acid-related orphan receptor alpha</p>
</def>
</def-item>
<def-item>
<term>SHH</term>
<def>
<p id="Par43">Sonic hedgehog</p>
</def>
</def-item>
<def-item>
<term>SMO</term>
<def>
<p id="Par44">Transmembrane protein Smoothened</p>
</def>
</def-item>
<def-item>
<term>TGF-β</term>
<def>
<p id="Par45">Transforming growth factor β</p>
</def>
</def-item>
<def-item>
<term>Tkv</term>
<def>
<p id="Par46">BMP type I receptor thickvein</p>
</def>
</def-item>
<def-item>
<term>UBE3A</term>
<def>
<p id="Par47">Ubiquitin-protein ligase E3A</p>
</def>
</def-item>
<def-item>
<term>VPA</term>
<def>
<p id="Par48">Valproic acid</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>We appreciate the technical assistance from Rebecca Donham, Yue Liu, and Taylor Imai during the manuscript preparation.</p>
<sec id="FPar21">
<title>Funding</title>
<p id="Par80">The Zhou Laboratory is supported by grants from the NIH (R01NS102261 and R01DE026737 to CZ) and the Shriners Hospitals for Children (85105 and 86600 to CZ).</p>
</sec>
<sec id="FPar22" sec-type="data-availability">
<title>Availability of data and materials</title>
<p id="Par81">Not applicable.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>KS conceptualized the subject, reviewed the literature, and wrote the draft manuscript. KR, YJ, RG, and SR assisted in the manuscript preparation. CZ initiated the topic, designed the figures, and revised and finalized the manuscript. All authors read and approved the final manuscript.</p>
</notes>
<notes>
<title>Ethics approval and consent to participate</title>
<p id="Par82">Not applicable.</p>
</notes>
<notes>
<title>Consent for publication</title>
<p id="Par83">Not applicable.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par84">The authors declare that they have no competing interests.</p>
</notes>
<notes>
<title>Publisher’s Note</title>
<p id="Par85">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<mixed-citation publication-type="other">Mohn JL, Alexander J, Pirone A, Palka CD, Lee SY, Mebane L, et al. Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities. Mol Psychiatry. 2014;19:1133–42.</mixed-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golden</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>De Rubeis</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Disrupted circuits in mouse models of autism spectrum disorder and intellectual disability</article-title>
<source/>Curr Opin Neurobiol
          <year>2017</year>
<volume>48</volume>
<fpage>106</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2017.11.006</pub-id>
<pub-id pub-id-type="pmid">29222989</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<mixed-citation publication-type="other">Werling DM, Brand H, An JY, Stone MR, Zhu L, Glessner JT, et al. An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder. Nat Genet. 2018;50:727–36.</mixed-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosmicki</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Howrigan</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Slowikowski</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lek</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples</article-title>
<source/>Nat Genet
          <year>2017</year>
<volume>49</volume>
<fpage>504</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="doi">10.1038/ng.3789</pub-id>
<pub-id pub-id-type="pmid">28191890</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tebbenkamp</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Muhle</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism</article-title>
<source/>Cell.
          <year>2013</year>
<volume>155</volume>
<fpage>997</fpage>
<lpage>1007</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.10.020</pub-id>
<pub-id pub-id-type="pmid">24267886</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cotney</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Muhle</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment</article-title>
<source/>Nat Commun
          <year>2015</year>
<volume>6</volume>
<fpage>6404</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms7404</pub-id>
<pub-id pub-id-type="pmid">25752243</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bae</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>JY</given-names>
</name>
</person-group>
<article-title>The Wnt signaling pathway and related therapeutic drugs in autism spectrum disorder</article-title>
<source/>Clin Psychopharmacol Neurosci
          <year>2018</year>
<volume>16</volume>
<fpage>129</fpage>
<lpage>135</lpage>
<pub-id pub-id-type="doi">10.9758/cpn.2018.16.2.129</pub-id>
<pub-id pub-id-type="pmid">29739125</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalkman</surname>
<given-names>HO</given-names>
</name>
</person-group>
<article-title>A review of the evidence for the canonical Wnt pathway in autism spectrum disorders</article-title>
<source/>Mol Autism.
          <year>2012</year>
<volume>3</volume>
<fpage>10</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-3-10</pub-id>
<pub-id pub-id-type="pmid">23083465</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulligan</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Cheyette</surname>
<given-names>BNR</given-names>
</name>
</person-group>
<article-title>Neurodevelopmental perspectives on Wnt signaling in psychiatry</article-title>
<source/>Mol Neuropsychiatry
          <year>2016</year>
<volume>2</volume>
<fpage>219</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1159/000453266</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Rui</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuroligin 4 regulates synaptic growth via the bone morphogenetic protein (BMP) signaling pathway at the Drosophila neuromuscular junction</article-title>
<source/>J Biol Chem
          <year>2017</year>
<volume>292</volume>
<fpage>17991</fpage>
<lpage>18005</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M117.810242</pub-id>
<pub-id pub-id-type="pmid">28912273</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kashima</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ascano</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martinez-Cerdeno</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ariza-Torres</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome</article-title>
<source/>Sci Signal
          <year>2016</year>
<volume>9</volume>
<fpage>ra58</fpage>
<pub-id pub-id-type="doi">10.1126/scisignal.aaf6060</pub-id>
<pub-id pub-id-type="pmid">27273096</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<mixed-citation publication-type="other">Li W, Yao A, Zhi H, Kaur K, Zhu YC, Jia M, et al. Angelman syndrome protein Ube3a regulates synaptic growth and endocytosis by inhibiting BMP signaling in Drosophila. PLoS Genet. 2016;12:e1006062.</mixed-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sajan</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JLR</given-names>
</name>
<name>
<surname>Warchol</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Lovett</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Identification of direct downstream targets of Dlx5 during early inner ear development</article-title>
<source/>Hum Mol Genet
          <year>2011</year>
<volume>20</volume>
<fpage>1262</fpage>
<lpage>1273</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddq567</pub-id>
<pub-id pub-id-type="pmid">21227998</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halepoto</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Bashir</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zeina</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Al-Ayadhi</surname>
<given-names>LY</given-names>
</name>
</person-group>
<article-title>Correlation between hedgehog (Hh) protein family and brain-derived neurotrophic factor (BDNF) in autism spectrum disorder (ASD)</article-title>
<source/>J Coll Physicians Surg Pak
          <year>2015</year>
<volume>25</volume>
<fpage>882</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="pmid">26691363</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Tomar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mahindroo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Udayabanu</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Targeting sonic hedgehog signaling in neurological disorders</article-title>
<source/>Neurosci Biobehav Rev
          <year>2017</year>
<volume>74</volume>
<fpage>76</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2017.01.008</pub-id>
<pub-id pub-id-type="pmid">28088536</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iwata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hevner</surname>
<given-names>RF</given-names>
</name>
</person-group>
<article-title>Fibroblast growth factor signaling in development of the cerebral cortex</article-title>
<source/>Develop Growth Differ
          <year>2009</year>
<volume>51</volume>
<fpage>299</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-169X.2009.01104.x</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ansari</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Attia</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Nadeem</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bakheet</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Raish</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>TH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activation of adenosine A2A receptor signaling regulates the expression of cytokines associated with immunologic dysfunction in BTBR T+Itpr3tf/J mice</article-title>
<source/>Mol Cell Neurosci
          <year>2017</year>
<volume>82</volume>
<fpage>76</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2017.04.012</pub-id>
<pub-id pub-id-type="pmid">28465254</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Guter</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Potter</surname>
<given-names>MH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism</article-title>
<source/>Mol Autism.
          <year>2017</year>
<volume>8</volume>
<fpage>14</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-017-0130-3</pub-id>
<pub-id pub-id-type="pmid">28344757</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<mixed-citation publication-type="other">Niculae AS, Pavăl D. From molecules to behavior: an integrative theory of autism spectrum disorder. Med Hypotheses. 2016;97:74–84.</mixed-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Downregulating the canonical Wnt/β-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress</article-title>
<source/>Neurochem Res
          <year>2012</year>
<volume>37</volume>
<fpage>1409</fpage>
<lpage>1419</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-012-0724-2</pub-id>
<pub-id pub-id-type="pmid">22374471</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<mixed-citation publication-type="other">Tang SJ. Synaptic activity-regulated Wnt signaling in synaptic plasticity, glial function and chronic pain. CNS Neurol Disord Drug Targets. 2014;13:737–44.</mixed-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wada</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Roles of noncanonical Wnt/PCP pathway genes in neuronal migration and neurulation in zebrafish</article-title>
<source/>Zebrafish.
          <year>2009</year>
<volume>6</volume>
<fpage>3</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1089/zeb.2008.0557</pub-id>
<pub-id pub-id-type="pmid">19250033</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wodarz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Mechanisms of Wnt signaling in development</article-title>
<source/>Annu Rev Cell Dev Biol
          <year>1998</year>
<volume>14</volume>
<fpage>59</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.cellbio.14.1.59</pub-id>
<pub-id pub-id-type="pmid">9891778</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosso</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Inestrosa</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>WNT signaling in neuronal maturation and synaptogenesis</article-title>
<source/>Front Cell Neurosci
          <year>2013</year>
<volume>7</volume>
<fpage>103</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2013.00103</pub-id>
<pub-id pub-id-type="pmid">23847469</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bielen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Houart</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>The Wnt cries many: Wnt regulation of neurogenesis through tissue patterning, proliferation, and asymmetric cell division</article-title>
<source/>Dev Neurobiol
          <year>2014</year>
<volume>74</volume>
<fpage>772</fpage>
<lpage>780</lpage>
<pub-id pub-id-type="doi">10.1002/dneu.22168</pub-id>
<pub-id pub-id-type="pmid">24488703</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abu-Khalil</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grove</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Zecevic</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
</person-group>
<article-title>Wnt genes define distinct boundaries in the developing human brain: implications for human forebrain patterning</article-title>
<source/>J Comp Neurol
          <year>2004</year>
<volume>474</volume>
<fpage>276</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.1002/cne.20112</pub-id>
<pub-id pub-id-type="pmid">15164427</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bengoa-Vergniory</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kypta</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Canonical and noncanonical Wnt signaling in neural stem/progenitor cells</article-title>
<source/>Cell Mol Life Sci
          <year>2015</year>
<volume>72</volume>
<fpage>4157</fpage>
<lpage>4172</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-015-2028-6</pub-id>
<pub-id pub-id-type="pmid">26306936</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burden</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Wnts as retrograde signals for axon and growth cone differentiation</article-title>
<source/>Cell.
          <year>2000</year>
<volume>100</volume>
<fpage>495</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80685-6</pub-id>
<pub-id pub-id-type="pmid">10721986</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inestrosa</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Varela-Nallar</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Wnt signalling in neuronal differentiation and development</article-title>
<source/>Cell Tissue Res
          <year>2015</year>
<volume>359</volume>
<fpage>215</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1007/s00441-014-1996-4</pub-id>
<pub-id pub-id-type="pmid">25234280</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onishi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hollis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Axon guidance and injury-lessons from Wnts and Wnt signaling</article-title>
<source/>Curr Opin Neurobiol
          <year>2014</year>
<volume>27</volume>
<fpage>232</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2014.05.005</pub-id>
<pub-id pub-id-type="pmid">24927490</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okerlund</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Cheyette</surname>
<given-names>BNR</given-names>
</name>
</person-group>
<article-title>Synaptic Wnt signaling-a contributor to major psychiatric disorders</article-title>
<source/>J Neurodev Disord
          <year>2011</year>
<volume>3</volume>
<fpage>162</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1007/s11689-011-9083-6</pub-id>
<pub-id pub-id-type="pmid">21533542</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oron</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Elliott</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Delineating the common biological pathways perturbed by ASD’s genetic etiology: lessons from network-based studies</article-title>
<source/>Int J Mol Sci
          <year>2017</year>
<volume>18</volume>
<fpage>828</fpage>
<pub-id pub-id-type="doi">10.3390/ijms18040828</pub-id>
<pub-id pub-id-type="pmid">5412412</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Unda</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>KK</given-names>
</name>
</person-group>
<article-title>Wnt signaling networks in autism spectrum disorder and intellectual disability</article-title>
<source/>J Neurodev Disord
          <year>2016</year>
<volume>8</volume>
<fpage>45</fpage>
<pub-id pub-id-type="doi">10.1186/s11689-016-9176-3</pub-id>
<pub-id pub-id-type="pmid">27980692</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<mixed-citation publication-type="other">Martin PM, Yang X, Robin N, Lam E, Rabinowitz JS, Erdman CA, et al. A rare WNT1 missense variant overrepresented in ASD leads to increased WNT signal pathway activation. Transl Psychiatry. 2013;3:e301.</mixed-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hormozdiari</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Penn</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Borenstein</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>The discovery of integrated gene networks for autism and related disorders</article-title>
<source/>Genome Res
          <year>2015</year>
<volume>25</volume>
<fpage>142</fpage>
<lpage>154</lpage>
<pub-id pub-id-type="doi">10.1101/gr.178855.114</pub-id>
<pub-id pub-id-type="pmid">25378250</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>A de novo convergence of autism genetics and molecular neuroscience</article-title>
<source/>Trends Neurosci
          <year>2014</year>
<volume>37</volume>
<fpage>95</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2013.11.005</pub-id>
<pub-id pub-id-type="pmid">24387789</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<mixed-citation publication-type="other">Grainger S, Willert K. Mechanisms of Wnt signaling and control. Wiley Interdiscip Rev Syst Biol Med. 2018:e1422.</mixed-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Komiya</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Habas</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Wnt signal transduction pathways</article-title>
<source/>Organogenesis.
          <year>2008</year>
<volume>4</volume>
<fpage>68</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.4161/org.4.2.5851</pub-id>
<pub-id pub-id-type="pmid">19279717</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karakoc</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</article-title>
<source/>Nature.
          <year>2012</year>
<volume>485</volume>
<fpage>246</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="doi">10.1038/nature10989</pub-id>
<pub-id pub-id-type="pmid">22495309</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sowers</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Loo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ulrich</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction</article-title>
<source/>Mol Psychiatry
          <year>2013</year>
<volume>18</volume>
<fpage>1077</fpage>
<lpage>1089</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.71</pub-id>
<pub-id pub-id-type="pmid">23711981</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wassink</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Piven</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vieland</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Swiderski</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Pietila</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evidence supporting WNT2 as an autism susceptibility gene</article-title>
<source/>Am J Med Genet
          <year>2001</year>
<volume>105</volume>
<fpage>406</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.1401</pub-id>
<pub-id pub-id-type="pmid">11449391</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marui</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Funatogawa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Koishi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>O</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between autism and variants in the wingless-type MMTV integration site family member 2 (WNT2) gene</article-title>
<source/>Int J Neuropsychopharmacol
          <year>2010</year>
<volume>13</volume>
<fpage>443</fpage>
<lpage>449</lpage>
<pub-id pub-id-type="doi">10.1017/S1461145709990903</pub-id>
<pub-id pub-id-type="pmid">19895723</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<mixed-citation publication-type="other">Lin PI, Chien YL, Wu YY, Chen CH, Gau SS, Huang YS, et al. The WNT2 gene polymorphism associated with speech delay inherent to autism. Res Dev Disabil. 2012;33:1533–40.</mixed-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ronemus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamrom</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Leotta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kendall</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare de novo and transmitted copy-number variation in autistic spectrum disorders</article-title>
<source/>Neuron.
          <year>2011</year>
<volume>70</volume>
<fpage>886</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.015</pub-id>
<pub-id pub-id-type="pmid">21658582</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<mixed-citation publication-type="other">Chow ML, Pramparo T, Winn ME, Barnes CC, Li HR, Weiss L, et al. Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages. PLoS Genet. 2012;8:e1002592.</mixed-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Capecchi</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Targeted disruption of the murine int-1 proto-oncogene resulting in severe abnormalities in midbrain and cerebellar development</article-title>
<source/>Nature.
          <year>1990</year>
<volume>346</volume>
<fpage>847</fpage>
<lpage>850</lpage>
<pub-id pub-id-type="doi">10.1038/346847a0</pub-id>
<pub-id pub-id-type="pmid">2202907</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMahon</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain</article-title>
<source/>Cell.
          <year>1990</year>
<volume>62</volume>
<fpage>1073</fpage>
<lpage>1085</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(90)90385-R</pub-id>
<pub-id pub-id-type="pmid">2205396</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMahon</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Joyner</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>The midbrain-hindbrain phenotype of Wnt-1-/Wnt-1- mice results from stepwise deletion of engrailed-expressing cells by 9.5 days postcoitum</article-title>
<source/>Cell.
          <year>1992</year>
<volume>69</volume>
<fpage>581</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="doi">10.1016/0092-8674(92)90222-X</pub-id>
<pub-id pub-id-type="pmid">1534034</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiester</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Galati</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Salinas</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>KR</given-names>
</name>
</person-group>
<article-title>Neurotrophin and Wnt signaling cooperatively regulate dendritic spine formation</article-title>
<source/>Mol Cell Neurosci
          <year>2013</year>
<volume>56</volume>
<fpage>115</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2013.04.006</pub-id>
<pub-id pub-id-type="pmid">23639831</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<mixed-citation publication-type="other">Lie DC, Colamarino SA, Song HJ, Désiré L, Mira H, Consiglio A, et al. Wnt signalling regulates adult hippocampal neurogenesis. Nature. 2005;437:1370–5.</mixed-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wakamiya</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shea</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Behringer</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Requirement for Wnt3 in vertebrate axis formation</article-title>
<source/>Nat Genet
          <year>1999</year>
<volume>22</volume>
<fpage>361</fpage>
<lpage>365</lpage>
<pub-id pub-id-type="doi">10.1038/11932</pub-id>
<pub-id pub-id-type="pmid">10431240</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<mixed-citation publication-type="other">Fazel Darbandi S, Robinson Schwartz SE, Qi Q, Catta-Preta R, Pai EL, Mandell JD, et al. Neonatal Tbr1 dosage controls cortical layer 6 connectivity. Neuron. 2018;100:831–845.e7.</mixed-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<mixed-citation publication-type="other">Jin YR, Han XH, Taketo MM, Yoon JK. Wnt9b-dependent FGF signaling is crucial for outgrowth of the nasal and maxillary processes during upper jaw and lip development. Development. 2012;139:1821–30.</mixed-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juriloff</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Lidral</surname>
<given-names>AC</given-names>
</name>
</person-group>
<article-title>Wnt9b is the mutated gene involved in multifactorial nonsyndromic cleft lip with or without cleft palate in A/WySn mice, as confirmed by a genetic complementation test</article-title>
<source/>Birth Defects Res A Clin Mol Teratol
          <year>2006</year>
<volume>76</volume>
<fpage>574</fpage>
<lpage>579</lpage>
<pub-id pub-id-type="doi">10.1002/bdra.20302</pub-id>
<pub-id pub-id-type="pmid">16998816</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacDonald</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling</article-title>
<source/>Cold Spring Harb Perspect Biol
          <year>2012</year>
<volume>4</volume>
<fpage>a007880</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a007880</pub-id>
<pub-id pub-id-type="pmid">23209147</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacDonald</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Tamai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Wnt/beta-catenin signaling: components, mechanisms, and diseases</article-title>
<source/>Dev Cell
          <year>2009</year>
<volume>17</volume>
<fpage>9</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="doi">10.1016/j.devcel.2009.06.016</pub-id>
<pub-id pub-id-type="pmid">19619488</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<mixed-citation publication-type="other">Zhou XL, Giacobini M, Anderlid BM, Anckarsäter H, Omrani D, Gillberg C, et al. Association of adenomatous polyposis coli (APC) gene polymorphisms with autism spectrum disorder (ASD). Am J Med Genet B Neuropsychiatr Genet. 2007;144B:351–4.</mixed-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barber</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Bowles</surname>
<given-names>LV</given-names>
</name>
<name>
<surname>Delhanty</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Ede</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Male</surname>
<given-names>BM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adenomatous polyposis coli and a cytogenetic deletion of chromosome 5 resulting from a maternal intrachromosomal insertion</article-title>
<source/>J Med Genet
          <year>1994</year>
<volume>31</volume>
<fpage>312</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.31.4.312</pub-id>
<pub-id pub-id-type="pmid">8071957</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clevers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Wnt/β-catenin signaling and disease</article-title>
<source/>Cell.
          <year>2012</year>
<volume>149</volume>
<fpage>1192</fpage>
<lpage>1205</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.05.012</pub-id>
<pub-id pub-id-type="pmid">22682243</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grigoryan</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wend</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Klaus</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Birchmeier</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice</article-title>
<source/>Genes Dev
          <year>2008</year>
<volume>22</volume>
<fpage>2308</fpage>
<lpage>2341</lpage>
<pub-id pub-id-type="doi">10.1101/gad.1686208</pub-id>
<pub-id pub-id-type="pmid">18765787</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuechler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bacino</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Bartholomew</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>van Bokhoven</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum</article-title>
<source/>Hum Genet
          <year>2015</year>
<volume>134</volume>
<fpage>97</fpage>
<lpage>109</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-014-1498-1</pub-id>
<pub-id pub-id-type="pmid">25326669</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Egertson</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Stanaway</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Phelps</surname>
<given-names>IG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders</article-title>
<source/>Science.
          <year>2012</year>
<volume>338</volume>
<fpage>1619</fpage>
<lpage>1622</lpage>
<pub-id pub-id-type="doi">10.1126/science.1227764</pub-id>
<pub-id pub-id-type="pmid">23160955</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Murtha</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Murdoch</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Raubeson</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations revealed by whole-exome sequencing are strongly associated with autism</article-title>
<source/>Nature.
          <year>2012</year>
<volume>485</volume>
<fpage>237</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1038/nature10945</pub-id>
<pub-id pub-id-type="pmid">22495306</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dubruc</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Putoux</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Labalme</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rougeot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sanlaville</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Edery</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency</article-title>
<source/>Am J Med Genet A
          <year>2014</year>
<volume>164A</volume>
<fpage>1571</fpage>
<lpage>1575</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36484</pub-id>
<pub-id pub-id-type="pmid">24668549</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Stokes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lassiter</surname>
<given-names>RNT</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>β-Catenin regulates Pax3 and Cdx2 for caudal neural tube closure and elongation</article-title>
<source/>Development.
          <year>2014</year>
<volume>141</volume>
<fpage>148</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="doi">10.1242/dev.101550</pub-id>
<pub-id pub-id-type="pmid">24284205</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McSweeney</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects</article-title>
<source/>Hum Mol Genet
          <year>2016</year>
<volume>25</volume>
<fpage>2738</fpage>
<lpage>2751</lpage>
<pub-id pub-id-type="pmid">27131348</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grant</surname>
<given-names>SFA</given-names>
</name>
<name>
<surname>Thorleifsson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Reynisdottir</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Benediktsson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Manolescu</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sainz</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes</article-title>
<source/>Nat Genet
          <year>2006</year>
<volume>38</volume>
<fpage>320</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1038/ng1732</pub-id>
<pub-id pub-id-type="pmid">16415884</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rubeis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Poultney</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cicek</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>
<source/>Nature.
          <year>2014</year>
<volume>515</volume>
<fpage>209</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1038/nature13772</pub-id>
<pub-id pub-id-type="pmid">25363760</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Ronemus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>
<source/>Nature.
          <year>2014</year>
<volume>515</volume>
<fpage>216</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1038/nature13908</pub-id>
<pub-id pub-id-type="pmid">25363768</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<mixed-citation publication-type="other">Zhou CJ, Pinson KI, Pleasure SJ. Severe defects in dorsal thalamic development in low-density lipoprotein receptor-related protein-6 mutants. J Neurosci. 2004;24:7632–9.</mixed-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tcf7l2 plays crucial roles in forebrain development through regulation of thalamic and habenular neuron identity and connectivity</article-title>
<source/>Dev Biol
          <year>2017</year>
<volume>424</volume>
<fpage>62</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2017.02.010</pub-id>
<pub-id pub-id-type="pmid">28219675</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okumura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Miyajima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shimojima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>3p interstitial deletion including PRICKLE2 in identical twins with autistic features</article-title>
<source/>Pediatr Neurol
          <year>2014</year>
<volume>51</volume>
<fpage>730</fpage>
<lpage>733</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2014.07.025</pub-id>
<pub-id pub-id-type="pmid">25193415</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagaoka</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tabuchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kishi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>PDZ interaction of Vangl2 links PSD-95 and Prickle2 but plays only a limited role in the synaptic localisation of Vangl2</article-title>
<source/>Sci Rep
          <year>2015</year>
<volume>5</volume>
<fpage>12916</fpage>
<pub-id pub-id-type="doi">10.1038/srep12916</pub-id>
<pub-id pub-id-type="pmid">26257100</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujimura</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Watanabe-Takano</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tokuhisa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hatano</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Prickle promotes neurite outgrowth via the Dishevelled dependent pathway in C1300 cells</article-title>
<source/>Neurosci Lett
          <year>2009</year>
<volume>467</volume>
<fpage>6</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2009.09.050</pub-id>
<pub-id pub-id-type="pmid">19788910</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Golhar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Otieno</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Whole-genome sequencing in an autism multiplex family</article-title>
<source/>Mol Autism.
          <year>2013</year>
<volume>4</volume>
<fpage>8</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-4-8</pub-id>
<pub-id pub-id-type="pmid">23597238</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iqbal</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Vandeweyer</surname>
<given-names>G</given-names>
</name>
<name>
<surname>van der Voet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Waryah</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Zahoor</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Besseling</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders</article-title>
<source/>Hum Mol Genet
          <year>2013</year>
<volume>22</volume>
<fpage>1960</fpage>
<lpage>1970</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddt043</pub-id>
<pub-id pub-id-type="pmid">23390136</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility</article-title>
<source/>Hum Mutat
          <year>2012</year>
<volume>33</volume>
<fpage>1635</fpage>
<lpage>1638</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22174</pub-id>
<pub-id pub-id-type="pmid">22865819</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yi</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Paranjape</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Choudhury</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wolter</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Fragola</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome</article-title>
<source/>J Biol Chem
          <year>2017</year>
<volume>292</volume>
<fpage>12503</fpage>
<lpage>12515</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M117.788448</pub-id>
<pub-id pub-id-type="pmid">28559284</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Meka</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>White</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Holzapfel</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>DIXDC1 phosphorylation and control of dendritic morphology are impaired by rare genetic variants</article-title>
<source/>Cell Rep
          <year>2016</year>
<volume>17</volume>
<fpage>1892</fpage>
<lpage>1904</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.047</pub-id>
<pub-id pub-id-type="pmid">27829159</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>CT</given-names>
</name>
<name>
<surname>Ussyshkin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rai-Bhogal</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Prostaglandin E2 promotes neural proliferation and differentiation and regulates Wnt target gene expression</article-title>
<source/>J Neurosci Res
          <year>2016</year>
<volume>94</volume>
<fpage>759</fpage>
<lpage>775</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.23759</pub-id>
<pub-id pub-id-type="pmid">27265882</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medina</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Caracci</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Avila</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Verdugo</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Vargas</surname>
<given-names>MF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Wnt/β-catenin signaling stimulates the expression and synaptic clustering of the autism-associated Neuroligin 3 gene</article-title>
<source/>Transl Psychiatry
          <year>2018</year>
<volume>8</volume>
<fpage>45</fpage>
<pub-id pub-id-type="doi">10.1038/s41398-018-0093-y</pub-id>
<pub-id pub-id-type="pmid">29503438</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hedstrom</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Ogawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Rasband</surname>
<given-names>MN</given-names>
</name>
</person-group>
<article-title>AnkyrinG is required for maintenance of the axon initial segment and neuronal polarity</article-title>
<source/>J Cell Biol
          <year>2008</year>
<volume>183</volume>
<fpage>635</fpage>
<lpage>640</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.200806112</pub-id>
<pub-id pub-id-type="pmid">19001126</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kordeli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>AnkyrinG. A new ankyrin gene with neural-specific isoforms localized at the axonal initial segment and node of Ranvier</article-title>
<source/>J Biol Chem
          <year>1995</year>
<volume>270</volume>
<fpage>2352</fpage>
<lpage>2359</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.270.5.2352</pub-id>
<pub-id pub-id-type="pmid">7836469</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kizhatil</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>JQ</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hogan</surname>
<given-names>BLM</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos</article-title>
<source/>J Biol Chem
          <year>2007</year>
<volume>282</volume>
<fpage>26552</fpage>
<lpage>26561</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M703158200</pub-id>
<pub-id pub-id-type="pmid">17620337</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Durak</surname>
<given-names>O</given-names>
</name>
<name>
<surname>de Anda</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Leussis</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Petryshen</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ankyrin-G regulates neurogenesis and Wnt signaling by altering the subcellular localization of β-catenin</article-title>
<source/>Mol Psychiatry
          <year>2015</year>
<volume>20</volume>
<fpage>388</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2014.42</pub-id>
<pub-id pub-id-type="pmid">24821222</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bochar</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes</article-title>
<source/>Mol Cell Biol
          <year>2008</year>
<volume>28</volume>
<fpage>3894</fpage>
<lpage>3904</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.00322-08</pub-id>
<pub-id pub-id-type="pmid">18378692</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishiyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Oshikawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tsukada</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iemura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Natsume</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis</article-title>
<source/>Nat Cell Biol
          <year>2009</year>
<volume>11</volume>
<fpage>172</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1038/ncb1831</pub-id>
<pub-id pub-id-type="pmid">19151705</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subtil-Rodríguez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vázquez-Chávez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ceballos-Chávez</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rodríguez-Paredes</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martín-Subero</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Esteller</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The chromatin remodeller CHD8 is required for E2F-dependent transcription activation of S-phase genes</article-title>
<source/>Nucleic Acids Res
          <year>2014</year>
<volume>42</volume>
<fpage>2185</fpage>
<lpage>2196</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkt1161</pub-id>
<pub-id pub-id-type="pmid">24265227</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<mixed-citation publication-type="other">Platt RJ, Zhou Y, Slaymaker IM, Shetty AS, Weisbach NR, Kim JA, et al. Chd8 mutation leads to autistic-like behaviors and impaired striatal circuits. Cell Rep. 2017;19:335–50.</mixed-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkinson</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Grepo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Evgrafov</surname>
<given-names>OV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The autism-associated gene chromodomain helicase DNA-binding protein 8 (CHD8) regulates noncoding RNAs and autism-related genes</article-title>
<source/>Transl Psychiatry
          <year>2015</year>
<volume>5</volume>
<fpage>e568</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2015.62</pub-id>
<pub-id pub-id-type="pmid">25989142</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<mixed-citation publication-type="other">Martin PM, Stanley RE, Ross AP, Freitas AE, Moyer CE, Brumback AC, et al. DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/β-catenin signaling. Mol Psychiatry. 2018;23:467–75.</mixed-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<mixed-citation publication-type="other">Kivimäe S, Martin PM, Kapfhamer D, Ruan Y, Heberlein U, Rubenstein JLR, et al. Abnormal behavior in mice mutant for the Disc1 binding partner, Dixdc1. Transl Psychiatry. 2011;1:e43.</mixed-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bandim</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>LO</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Costa</surname>
<given-names>AES</given-names>
</name>
</person-group>
<article-title>Autism and Möbius sequence: an exploratory study of children in northeastern Brazil</article-title>
<source/>Arq Neuropsiquiatr
          <year>2003</year>
<volume>61</volume>
<fpage>181</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.1590/S0004-282X2003000200004</pub-id>
<pub-id pub-id-type="pmid">12806493</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landrigan</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>What causes autism? Exploring the environmental contribution</article-title>
<source/>Curr Opin Pediatr
          <year>2010</year>
<volume>22</volume>
<fpage>219</fpage>
<lpage>225</lpage>
<pub-id pub-id-type="doi">10.1097/MOP.0b013e328336eb9a</pub-id>
<pub-id pub-id-type="pmid">20087185</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jamain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Quach</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Betancur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Råstam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Colineaux</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>IC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism</article-title>
<source/>Nat Genet
          <year>2003</year>
<volume>34</volume>
<fpage>27</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1038/ng1136</pub-id>
<pub-id pub-id-type="pmid">12669065</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chapnick</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Dynamics of TGF-β/Smad signaling</article-title>
<source/>FEBS Lett
          <year>2012</year>
<volume>586</volume>
<fpage>1921</fpage>
<lpage>1928</lpage>
<pub-id pub-id-type="doi">10.1016/j.febslet.2012.03.063</pub-id>
<pub-id pub-id-type="pmid">22710166</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lowery</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Bone morphogenetic protein-based therapeutic approaches</article-title>
<source/>Cold Spring Harb Perspect Biol
          <year>2018</year>
<volume>10</volume>
<fpage>a022327</fpage>
<pub-id pub-id-type="doi">10.1101/cshperspect.a022327</pub-id>
<pub-id pub-id-type="pmid">28389444</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bond</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Bhalala</surname>
<given-names>OG</given-names>
</name>
<name>
<surname>Kessler</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation</article-title>
<source/>Dev Neurobiol.
          <year>2012</year>
<volume>72</volume>
<fpage>1068</fpage>
<lpage>1084</lpage>
<pub-id pub-id-type="doi">10.1002/dneu.22022</pub-id>
<pub-id pub-id-type="pmid">22489086</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Qiao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Peabody</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bone morphogenetic protein (BMP) signaling in development and human diseases</article-title>
<source/>Genes Dis
          <year>2014</year>
<volume>1</volume>
<fpage>87</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.gendis.2014.07.005</pub-id>
<pub-id pub-id-type="pmid">25401122</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamilton</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Woo</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Ghanem</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ekker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JLR</given-names>
</name>
</person-group>
<article-title>Analysis of four DLX homeobox genes in autistic probands</article-title>
<source/>BMC Genet
          <year>2005</year>
<volume>6</volume>
<fpage>52</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2156-6-52</pub-id>
<pub-id pub-id-type="pmid">16266434</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Novosedlik</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hudson</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>IL</given-names>
</name>
<name>
<surname>Chudley</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The DLX1and DLX2 genes and susceptibility to autism spectrum disorders</article-title>
<source/>Eur J Hum Genet
          <year>2009</year>
<volume>17</volume>
<fpage>228</fpage>
<lpage>235</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2008.148</pub-id>
<pub-id pub-id-type="pmid">18728693</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubenstein</surname>
<given-names>JLR</given-names>
</name>
<name>
<surname>Merzenich</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Model of autism: increased ratio of excitation/inhibition in key neural systems</article-title>
<source/>Genes Brain Behav
          <year>2003</year>
<volume>2</volume>
<fpage>255</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1034/j.1601-183X.2003.00037.x</pub-id>
<pub-id pub-id-type="pmid">14606691</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choy</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>SH</given-names>
</name>
</person-group>
<article-title>Hedgehog signaling</article-title>
<source/>Vitam Horm
          <year>2012</year>
<volume>88</volume>
<fpage>1</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1016/B978-0-12-394622-5.00001-8</pub-id>
<pub-id pub-id-type="pmid">22391297</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Álvarez-Buylla</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ihrie</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Sonic hedgehog signaling in the postnatal brain</article-title>
<source/>Semin Cell Dev Biol
          <year>2014</year>
<volume>33</volume>
<fpage>105</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1016/j.semcdb.2014.05.008</pub-id>
<pub-id pub-id-type="pmid">24862855</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirschen</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>Q</given-names>
</name>
</person-group>
<article-title>Primary cilia as a novel horizon between neuron and environment</article-title>
<source/>Neural Regen Res
          <year>2017</year>
<volume>12</volume>
<fpage>1225</fpage>
<lpage>1230</lpage>
<pub-id pub-id-type="doi">10.4103/1673-5374.213535</pub-id>
<pub-id pub-id-type="pmid">28966631</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seppala</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fraser</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Birjandi</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Xavier</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Cobourne</surname>
<given-names>MT</given-names>
</name>
</person-group>
<article-title>Sonic hedgehog signaling and development of the dentition</article-title>
<source/>J Dev Biol
          <year>2017</year>
<volume>5</volume>
<fpage>6</fpage>
<pub-id pub-id-type="doi">10.3390/jdb5020006</pub-id>
<pub-id pub-id-type="pmid">5831762</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghanizadeh</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Malondialdehyde, Bcl-2, superoxide dismutase and glutathione peroxidase may mediate the association of sonic hedgehog protein and oxidative stress in autism</article-title>
<source/>Neurochem Res
          <year>2012</year>
<volume>37</volume>
<fpage>899</fpage>
<lpage>901</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-011-0667-z</pub-id>
<pub-id pub-id-type="pmid">22143957</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Ayadhi</surname>
<given-names>LY</given-names>
</name>
</person-group>
<article-title>Relationship between sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders</article-title>
<source/>Neurochem Res
          <year>2012</year>
<volume>37</volume>
<fpage>394</fpage>
<lpage>400</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-011-0624-x</pub-id>
<pub-id pub-id-type="pmid">21984201</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<mixed-citation publication-type="other">Tora D, Gomez AM, Michaud JF, Yam PT, Charron F, Scheiffele P. Cellular functions of the autism risk factor PTCHD1 in mice. J Neurosci. 2017;37:11993–2005.</mixed-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<mixed-citation publication-type="other">Ung DC, Iacono G, Méziane H, Blanchard E, Papon MA, Selten M, et al. Ptchd1 deficiency induces excitatory synaptic and cognitive dysfunctions in mouse. Mol Psychiatry. 2017.</mixed-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blassberg</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Macrae</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Briscoe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jacob</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Reduced cholesterol levels impair Smoothened activation in Smith-Lemli-Opitz syndrome</article-title>
<source/>Hum Mol Genet
          <year>2016</year>
<volume>25</volume>
<fpage>693</fpage>
<lpage>705</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddv507</pub-id>
<pub-id pub-id-type="pmid">26685159</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brune</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Korvatska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Allen-Brady</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Heterogeneous association between engrailed-2 and autism in the CPEA network</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2008</year>
<volume>147B</volume>
<fpage>187</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30585</pub-id>
<pub-id pub-id-type="pmid">17948868</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Family-based studies indicate association of Engrailed 2 gene with autism in an Indian population</article-title>
<source/>Genes Brain Behav.
          <year>2010</year>
<volume>9</volume>
<fpage>248</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2009.00556.x</pub-id>
<pub-id pub-id-type="pmid">20050924</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of the ENGRAILED 2 (EN2) gene with autism in Chinese Han population</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2008</year>
<volume>147B</volume>
<fpage>434</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.30623</pub-id>
<pub-id pub-id-type="pmid">17948901</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<mixed-citation publication-type="other">Yang P, Lung FW, Jong YJ, Hsieh HY, Liang CL, Juo SH. Association of the homeobox transcription factor gene ENGRAILED 2 with autistic disorder in Chinese children. Neuropsychobiology. 2008;57:3–8.</mixed-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<mixed-citation publication-type="other">Yang P, Shu B-C, Hallmayer JF, Lung FW. Intronic single nucleotide polymorphisms of engrailed homeobox 2 modulate the disease vulnerability of autism in a Han Chinese population. Neuropsychobiology. 2010;62:104–15.</mixed-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ababon</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Soliman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Brzustowicz</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Matteson</surname>
<given-names>PG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Autism associated gene, engrailed2, and flanking gene levels are altered in post-mortem cerebellum</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e87208</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0087208</pub-id>
<pub-id pub-id-type="pmid">24520327</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gharani</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Benayed</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mancuso</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Brzustowicz</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Millonig</surname>
<given-names>JH</given-names>
</name>
</person-group>
<article-title>Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder</article-title>
<source/>Mol Psychiatry
          <year>2004</year>
<volume>9</volume>
<fpage>474</fpage>
<lpage>484</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4001498</pub-id>
<pub-id pub-id-type="pmid">15024396</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wechsler-Reya</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>MP</given-names>
</name>
</person-group>
<article-title>Control of neuronal precursor proliferation in the cerebellum by sonic hedgehog</article-title>
<source/>Neuron.
          <year>1999</year>
<volume>22</volume>
<fpage>103</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80682-0</pub-id>
<pub-id pub-id-type="pmid">10027293</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simon</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Scholz</surname>
<given-names>C</given-names>
</name>
<name>
<surname>O’Leary</surname>
<given-names>DDM</given-names>
</name>
</person-group>
<article-title>Engrailed genes control developmental fate of serotonergic and noradrenergic neurons in mid- and hindbrain in a gene dose-dependent manner</article-title>
<source/>Mol Cell Neurosci
          <year>2005</year>
<volume>28</volume>
<fpage>96</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2004.08.016</pub-id>
<pub-id pub-id-type="pmid">15607945</pub-id>
</element-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Eren-Koçak</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Inui</surname>
<given-names>EG</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Akil</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Dysregulated fibroblast growth factor (FGF) signaling in neurological and psychiatric disorders</article-title>
<source/>Semin Cell Dev Biol
          <year>2016</year>
<volume>53</volume>
<fpage>136</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1016/j.semcdb.2015.10.003</pub-id>
<pub-id pub-id-type="pmid">26454097</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ornitz</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Itoh</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>The fibroblast growth factor signaling pathway</article-title>
<source/>Wiley Interdiscip Rev Dev Biol
          <year>2015</year>
<volume>4</volume>
<fpage>215</fpage>
<lpage>266</lpage>
<pub-id pub-id-type="doi">10.1002/wdev.176</pub-id>
<pub-id pub-id-type="pmid">25772309</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amaral</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Nordahl</surname>
<given-names>CW</given-names>
</name>
</person-group>
<article-title>Neuroanatomy of autism</article-title>
<source/>Trends Neurosci
          <year>2008</year>
<volume>31</volume>
<fpage>137</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2007.12.005</pub-id>
<pub-id pub-id-type="pmid">18258309</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Terauchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Johnson-Venkatesh</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Javed</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Umemori</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Distinct FGFs promote differentiation of excitatory and inhibitory synapses</article-title>
<source/>Nature.
          <year>2010</year>
<volume>465</volume>
<fpage>783</fpage>
<lpage>787</lpage>
<pub-id pub-id-type="doi">10.1038/nature09041</pub-id>
<pub-id pub-id-type="pmid">20505669</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<mixed-citation publication-type="other">Huang JY, Lu HC. mGluR5 tunes NGF/TrkA signaling to orient spiny stellate neuron dendrites toward thalamocortical axons during whisker-barrel map formation. Cereb Cortex. 2017:1–16.</mixed-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niederreither</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Dollé</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Retinoic acid in development: towards an integrated view</article-title>
<source/>Nat Rev Genet
          <year>2008</year>
<volume>9</volume>
<fpage>541</fpage>
<lpage>553</lpage>
<pub-id pub-id-type="doi">10.1038/nrg2340</pub-id>
<pub-id pub-id-type="pmid">18542081</pub-id>
</element-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Duester</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Retinoic acid synthesis and signaling during early organogenesis</article-title>
<source/>Cell.
          <year>2008</year>
<volume>134</volume>
<fpage>921</fpage>
<lpage>931</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.09.002</pub-id>
<pub-id pub-id-type="pmid">18805086</pub-id>
</element-citation>
</ref>
<ref id="CR128">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhinn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dollé</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Retinoic acid signalling during development</article-title>
<source/>Development.
          <year>2012</year>
<volume>139</volume>
<fpage>843</fpage>
<lpage>858</lpage>
<pub-id pub-id-type="doi">10.1242/dev.065938</pub-id>
<pub-id pub-id-type="pmid">22318625</pub-id>
</element-citation>
</ref>
<ref id="CR129">
<label>129.</label>
<mixed-citation publication-type="other">Das BC, Thapa P, Karki R, Das S, Mahapatra S, Liu TC, et al. Retinoic acid signaling pathways in development and diseases. Bioorg Med Chem. 2014;22:673–83.</mixed-citation>
</ref>
<ref id="CR130">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zieger</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>New insights into the roles of retinoic acid signaling in nervous system development and the establishment of neurotransmitter systems</article-title>
<source/>Int Rev Cell Mol Biol
          <year>2017</year>
<volume>330</volume>
<fpage>1</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1016/bs.ircmb.2016.09.001</pub-id>
<pub-id pub-id-type="pmid">28215529</pub-id>
</element-citation>
</ref>
<ref id="CR131">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siegenthaler</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ashique</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Zarbalis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Hecht</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Kane</surname>
<given-names>MA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Retinoic acid from the meninges regulates cortical neuron generation</article-title>
<source/>Cell.
          <year>2009</year>
<volume>139</volume>
<fpage>597</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2009.10.004</pub-id>
<pub-id pub-id-type="pmid">19879845</pub-id>
</element-citation>
</ref>
<ref id="CR132">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vitamin a deficiency induces autistic-like behaviors in rats by regulating the RARβ-CD38-oxytocin axis in the hypothalamus</article-title>
<source/>Mol Nutr Food Res
          <year>2018</year>
<volume>62</volume>
<fpage>1700754</fpage>
<pub-id pub-id-type="doi">10.1002/mnfr.201700754</pub-id>
</element-citation>
</ref>
<ref id="CR133">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rauch</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Pfeifer</surname>
<given-names>GP</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>VW</given-names>
</name>
</person-group>
<article-title>Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain</article-title>
<source/>FASEB J
          <year>2010</year>
<volume>24</volume>
<fpage>3036</fpage>
<lpage>3051</lpage>
<pub-id pub-id-type="doi">10.1096/fj.10-154484</pub-id>
<pub-id pub-id-type="pmid">20375269</pub-id>
</element-citation>
</ref>
<ref id="CR134">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sayad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Noroozi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Omrani</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Taheri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ghafouri-Fard</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Retinoic acid-related orphan receptor alpha (RORA) variants are associated with autism spectrum disorder</article-title>
<source/>Metab Brain Dis
          <year>2017</year>
<volume>32</volume>
<fpage>1595</fpage>
<lpage>1601</lpage>
<pub-id pub-id-type="doi">10.1007/s11011-017-0049-6</pub-id>
<pub-id pub-id-type="pmid">28608249</pub-id>
</element-citation>
</ref>
<ref id="CR135">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno-Ramos</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Olivares</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Haider</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>de Autismo</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Lattig</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Whole-exome sequencing in a South American cohort links ALDH1A3, FOXN1 and retinoic acid regulation pathways to autism spectrum disorders</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<fpage>e0135927</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0135927</pub-id>
<pub-id pub-id-type="pmid">26352270</pub-id>
</element-citation>
</ref>
<ref id="CR136">
<label>136.</label>
<mixed-citation publication-type="other">Pavăl D, Rad F, Rusu R, Niculae AS, Colosi HA, Dobrescu I, et al. Low retinal dehydrogenase 1 (RALDH1) level in prepubertal boys with autism spectrum disorder: a possible link to dopamine dysfunction. Clin Psychopharmacol Neurosci. 2017;15:229–36.</mixed-citation>
</ref>
<ref id="CR137">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fregeau</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Hernández-García</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Schnur</surname>
<given-names>RE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations of RERE cause a genetic syndrome with features that overlap those associated with proximal 1p36 deletions</article-title>
<source/>Am J Hum Genet
          <year>2016</year>
<volume>98</volume>
<fpage>963</fpage>
<lpage>970</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.03.002</pub-id>
<pub-id pub-id-type="pmid">27087320</pub-id>
</element-citation>
</ref>
<ref id="CR138">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarachana</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>VW</given-names>
</name>
</person-group>
<article-title>Genome-wide identification of transcriptional targets of RORA reveals direct regulation of multiple genes associated with autism spectrum disorder</article-title>
<source/>Mol Autism
          <year>2013</year>
<volume>4</volume>
<fpage>14</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-4-14</pub-id>
<pub-id pub-id-type="pmid">23697635</pub-id>
</element-citation>
</ref>
<ref id="CR139">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Excessive UBE3A dosage impairs retinoic acid signaling and synaptic plasticity in autism spectrum disorders</article-title>
<source/>Cell Res
          <year>2018</year>
<volume>28</volume>
<fpage>48</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1038/cr.2017.132</pub-id>
<pub-id pub-id-type="pmid">29076503</pub-id>
</element-citation>
</ref>
<ref id="CR140">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riebold</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mankuta</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lerer</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Israel</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nemanov</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from autism spectrum disorder</article-title>
<source/>Mol Med
          <year>2011</year>
<volume>17</volume>
<fpage>799</fpage>
<lpage>806</lpage>
<pub-id pub-id-type="doi">10.2119/molmed.2011.00080</pub-id>
<pub-id pub-id-type="pmid">21528155</pub-id>
</element-citation>
</ref>
<ref id="CR141">
<label>141.</label>
<mixed-citation publication-type="other">Kim S, Kim T, Lee HR, Jang EH, Ryu HH, Kang M, et al. Impaired learning and memory in CD38 null mutant mice. Mol Brain. 2016;9:16.</mixed-citation>
</ref>
<ref id="CR142">
<label>142.</label>
<mixed-citation publication-type="other">Avraham Y, Berry EM, Donskoy M, Ahmad WA, Vorobiev L, Albeck A, et al. Beta-carotene as a novel therapy for the treatment of “autistic like behavior” in animal models of autism. Behav Brain Res. 2017.</mixed-citation>
</ref>
<ref id="CR143">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Billon</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Burris</surname>
<given-names>TP</given-names>
</name>
</person-group>
<article-title>Therapeutic effect of a synthetic RORα/γ agonist in an animal model of autism</article-title>
<source/>ACS Chem Neurosci
          <year>2016</year>
<volume>7</volume>
<fpage>143</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1021/acschemneuro.5b00159</pub-id>
<pub-id pub-id-type="pmid">26625251</pub-id>
</element-citation>
</ref>
<ref id="CR144">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsarovina</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Reiff</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Stubbusch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kurek</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Grosveld</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Parlato</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Gata3 transcription factor is required for the survival of embryonic and adult sympathetic neurons</article-title>
<source/>J Neurosci
          <year>2010</year>
<volume>30</volume>
<fpage>10833</fpage>
<lpage>10843</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0175-10.2010</pub-id>
<pub-id pub-id-type="pmid">20702712</pub-id>
</element-citation>
</ref>
<ref id="CR145">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Notani</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gottimukkala</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Jayani</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Limaye</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Damle</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner</article-title>
<source/>PLoS Biol
          <year>2010</year>
<volume>8</volume>
<fpage>e1000296</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1000296</pub-id>
<pub-id pub-id-type="pmid">20126258</pub-id>
</element-citation>
</ref>
<ref id="CR146">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>HW</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hyeon</surname>
<given-names>JY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A probiotic mixture regulates T cell balance and reduces atopic dermatitis symptoms in mice</article-title>
<source/>Front Microbiol
          <year>2018</year>
<volume>9</volume>
<fpage>2414</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2018.02414</pub-id>
<pub-id pub-id-type="pmid">30374337</pub-id>
</element-citation>
</ref>
<ref id="CR147">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forsman</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Heinze</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sergi</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gopalakrishnan</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>BMP-binding protein twisted gastrulation is required in mammary gland epithelium for normal ductal elongation and myoepithelial compartmentalization</article-title>
<source/>Dev Biol
          <year>2013</year>
<volume>373</volume>
<fpage>95</fpage>
<lpage>106</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2012.10.007</pub-id>
<pub-id pub-id-type="pmid">23103586</pub-id>
</element-citation>
</ref>
<ref id="CR148">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rout</surname>
<given-names>UK</given-names>
</name>
<name>
<surname>Clausen</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Common increase of GATA-3 level in PC-12 cells by three teratogens causing autism spectrum disorders</article-title>
<source/>Neurosci Res
          <year>2009</year>
<volume>64</volume>
<fpage>162</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1016/j.neures.2009.02.009</pub-id>
<pub-id pub-id-type="pmid">19428696</pub-id>
</element-citation>
</ref>
<ref id="CR149">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chess</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Autism in children with congenital rubella</article-title>
<source/>J Autism Child Schizophr
          <year>1971</year>
<volume>1</volume>
<fpage>33</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1007/BF01537741</pub-id>
<pub-id pub-id-type="pmid">5172438</pub-id>
</element-citation>
</ref>
<ref id="CR150">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richetto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Massart</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Weber-Stadlbauer</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Szyf</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Riva</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Genome-wide DNA methylation changes in a mouse model of infection-mediated neurodevelopmental disorders</article-title>
<source/>Biol Psychiatry
          <year>2017</year>
<volume>81</volume>
<fpage>265</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2016.08.010</pub-id>
<pub-id pub-id-type="pmid">27769567</pub-id>
</element-citation>
</ref>
<ref id="CR151">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moore</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Turnpenny</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Glover</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lloyd</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A clinical study of 57 children with fetal anticonvulsant syndromes</article-title>
<source/>J Med Genet
          <year>2000</year>
<volume>37</volume>
<fpage>489</fpage>
<lpage>497</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.37.7.489</pub-id>
<pub-id pub-id-type="pmid">10882750</pub-id>
</element-citation>
</ref>
<ref id="CR152">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Effect of sulindac on improving autistic behaviors in rats</article-title>
<source/>Nan Fang Yi Ke Da Xue Xue Bao
          <year>2015</year>
<volume>35</volume>
<fpage>1162</fpage>
<lpage>1165</lpage>
<pub-id pub-id-type="pmid">26277514</pub-id>
</element-citation>
</ref>
<ref id="CR153">
<label>153.</label>
<mixed-citation publication-type="other">Song L, Li ZY, Liu WP, Zhao MR. Crosstalk between Wnt/β-catenin and hedgehog/Gli signaling pathways in colon cancer and implications for therapy. Cancer Biol Ther. 2015;16:1–7.</mixed-citation>
</ref>
<ref id="CR154">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Evidence for the direct involvement of βTrCP in Gli3 protein processing</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2006</year>
<volume>103</volume>
<fpage>33</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0509927103</pub-id>
<pub-id pub-id-type="pmid">16371461</pub-id>
</element-citation>
</ref>
<ref id="CR155">
<label>155.</label>
<mixed-citation publication-type="other">Tempé D, Casas M, Karaz S, Blanchet-Tournier M-F, Concordet JP. Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP. Mol Cell Biol. 2006;26:4316–26.</mixed-citation>
</ref>
<ref id="CR156">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hart</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Concordet</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Lassot</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Albert</surname>
<given-names>I</given-names>
</name>
<name>
<surname>del los Santos</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Durand</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell</article-title>
<source/>Curr Biol
          <year>1999</year>
<volume>9</volume>
<fpage>207</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="doi">10.1016/S0960-9822(99)80091-8</pub-id>
<pub-id pub-id-type="pmid">10074433</pub-id>
</element-citation>
</ref>
<ref id="CR157">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varnat</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Siegl-Cachedenier</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Malerba</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gervaz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ruiz i Altaba</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Loss of WNT-TCF addiction and enhancement of HH-GLI1 signalling define the metastatic transition of human colon carcinomas</article-title>
<source/>EMBO Mol Med
          <year>2010</year>
<volume>2</volume>
<fpage>440</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="doi">10.1002/emmm.201000098</pub-id>
<pub-id pub-id-type="pmid">20941789</pub-id>
</element-citation>
</ref>
<ref id="CR158">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Poon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cheah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Hui</surname>
<given-names>CC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Suppressor of fused negatively regulates beta-catenin signaling</article-title>
<source/>J Biol Chem
          <year>2001</year>
<volume>276</volume>
<fpage>40113</fpage>
<lpage>40119</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M105317200</pub-id>
<pub-id pub-id-type="pmid">11477086</pub-id>
</element-citation>
</ref>
<ref id="CR159">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dunaeva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Michelson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kogerman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Toftgard</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Characterization of the physical interaction of Gli proteins with SUFU proteins</article-title>
<source/>J Biol Chem
          <year>2003</year>
<volume>278</volume>
<fpage>5116</fpage>
<lpage>5122</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M209492200</pub-id>
<pub-id pub-id-type="pmid">12426310</pub-id>
</element-citation>
</ref>
<ref id="CR160">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tukachinsky</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lopez</surname>
<given-names>LV</given-names>
</name>
<name>
<surname>Salic</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A mechanism for vertebrate hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes</article-title>
<source/>J Cell Biol
          <year>2010</year>
<volume>191</volume>
<fpage>415</fpage>
<lpage>428</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.201004108</pub-id>
<pub-id pub-id-type="pmid">20956384</pub-id>
</element-citation>
</ref>
<ref id="CR161">
<label>161.</label>
<mixed-citation publication-type="other">Rychahou PG, Kang J, Gulhati P, Doan HQ, Chen LA, Xiao SY, et al. Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis. Proc Natl Acad Sci U S A. 2008;105:20315–20.</mixed-citation>
</ref>
<ref id="CR162">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arimura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Matsunaga</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kitamura</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Taketo</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling</article-title>
<source/>Gastroenterology.
          <year>2009</year>
<volume>137</volume>
<fpage>629</fpage>
<lpage>638</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2009.04.059</pub-id>
<pub-id pub-id-type="pmid">19427313</pub-id>
</element-citation>
</ref>
<ref id="CR163">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulloa</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Itasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Briscoe</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Inhibitory Gli3 activity negatively regulates Wnt/beta-catenin signaling</article-title>
<source/>Curr Biol
          <year>2007</year>
<volume>17</volume>
<fpage>545</fpage>
<lpage>550</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2007.01.062</pub-id>
<pub-id pub-id-type="pmid">17331723</pub-id>
</element-citation>
</ref>
<ref id="CR164">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lobo-Ruppert</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Ruppert</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Gli1 acts through Snail and E-cadherin to promote nuclear signaling by beta-catenin</article-title>
<source/>Oncogene.
          <year>2007</year>
<volume>26</volume>
<fpage>4489</fpage>
<lpage>4498</lpage>
<pub-id pub-id-type="doi">10.1038/sj.onc.1210241</pub-id>
<pub-id pub-id-type="pmid">17297467</pub-id>
</element-citation>
</ref>
<ref id="CR165">
<label>165.</label>
<mixed-citation publication-type="other">Javelaud D, Pierrat MJ, Mauviel A. Crosstalk between TGF-β and hedgehog signaling in cancer. FEBS Lett. 2012;586:2016–25.</mixed-citation>
</ref>
<ref id="CR166">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Crosstalk between Shh and TGF-β signaling in cyclosporine-enhanced cell proliferation in human gingival fibroblasts</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e70128</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0070128</pub-id>
<pub-id pub-id-type="pmid">23922933</pub-id>
</element-citation>
</ref>
<ref id="CR167">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glinka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Stoilova</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mohammed</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Prud’homme</surname>
<given-names>GJ</given-names>
</name>
</person-group>
<article-title>Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta</article-title>
<source/>Carcinogenesis.
          <year>2011</year>
<volume>32</volume>
<fpage>613</fpage>
<lpage>621</lpage>
<pub-id pub-id-type="doi">10.1093/carcin/bgq281</pub-id>
<pub-id pub-id-type="pmid">21186301</pub-id>
</element-citation>
</ref>
<ref id="CR168">
<label>168.</label>
<mixed-citation publication-type="other">Hillman RT, Feng BY, Ni J, Woo WM, Milenkovic L, Hayden Gephart MG, et al. Neuropilins are positive regulators of hedgehog signal transduction. Genes Dev. 2011;25:2333–46.</mixed-citation>
</ref>
<ref id="CR169">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hochman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Castiel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jacob-Hirsch</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Amariglio</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Izraeli</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Molecular pathways regulating pro-migratory effects of hedgehog signaling</article-title>
<source/>J Biol Chem
          <year>2006</year>
<volume>281</volume>
<fpage>33860</fpage>
<lpage>33870</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M605905200</pub-id>
<pub-id pub-id-type="pmid">16943197</pub-id>
</element-citation>
</ref>
<ref id="CR170">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sheng</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sinha</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Luxon</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Requirement of TGFbeta signaling for SMO-mediated carcinogenesis</article-title>
<source/>J Biol Chem
          <year>2010</year>
<volume>285</volume>
<fpage>36570</fpage>
<lpage>36576</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.C110.164442</pub-id>
<pub-id pub-id-type="pmid">20858897</pub-id>
</element-citation>
</ref>
<ref id="CR171">
<label>171.</label>
<mixed-citation publication-type="other">Pierrat MJ, Marsaud V, Mauviel A, Javelaud D. Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-β. J Biol Chem. 2012;287:17996–8004.</mixed-citation>
</ref>
<ref id="CR172">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stulberg</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Holley</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>Crosstalk between Fgf and Wnt signaling in the zebrafish tailbud</article-title>
<source/>Dev Biol
          <year>2012</year>
<volume>369</volume>
<fpage>298</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2012.07.003</pub-id>
<pub-id pub-id-type="pmid">22796649</pub-id>
</element-citation>
</ref>
<ref id="CR173">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>The canonical Wnt/β-catenin signaling pathway regulates Fgf signaling for early facial development</article-title>
<source/>Dev Biol
          <year>2011</year>
<volume>349</volume>
<fpage>250</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2010.11.004</pub-id>
<pub-id pub-id-type="pmid">21070765</pub-id>
</element-citation>
</ref>
<ref id="CR174">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hoppler</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship</article-title>
<source/>Dev Dyn
          <year>2010</year>
<volume>239</volume>
<fpage>16</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="pmid">19544585</pub-id>
</element-citation>
</ref>
<ref id="CR175">
<label>175.</label>
<mixed-citation publication-type="other">Song L, Li Y, Wang K, Wang YZ, Molotkov A, Gao L, et al. Lrp6-mediated canonical Wnt signaling is required for lip formation and fusion. Development. 2009;136:3161–71.</mixed-citation>
</ref>
<ref id="CR176">
<label>176.</label>
<mixed-citation publication-type="other">Zhou CJ, Wang YZ, Yamagami T, Zhao T, Song L, Wang K. Generation of Lrp6 conditional gene-targeting mouse line for modeling and dissecting multiple birth defects/congenital anomalies. Dev Dyn. 2010;239:318–26.</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>